Project
Illumina Body Map 2
Navigation
Downloads
Results for ZNF711_TFAP2A_TFAP2D
Z-value: 3.36
Motif logo
Transcription factors associated with ZNF711_TFAP2A_TFAP2D
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF711
|
ENSG00000147180.12 | zinc finger protein 711 |
|
TFAP2A
|
ENSG00000137203.6 | transcription factor AP-2 alpha |
|
TFAP2D
|
ENSG00000008197.4 | transcription factor AP-2 delta |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZNF711 | hg19_v2_chrX_+_84499081_84499115 | -0.70 | 9.7e-06 | Click! |
| TFAP2D | hg19_v2_chr6_+_50681541_50681541 | -0.55 | 1.2e-03 | Click! |
| TFAP2A | hg19_v2_chr6_-_10415470_10415508 | -0.31 | 8.7e-02 | Click! |
Activity profile of ZNF711_TFAP2A_TFAP2D motif
Sorted Z-values of ZNF711_TFAP2A_TFAP2D motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_33793430 | 10.23 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
| chr2_-_21266935 | 10.15 |
ENST00000233242.1
|
APOB
|
apolipoprotein B |
| chr19_-_45826125 | 10.05 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
| chr1_-_201398985 | 9.60 |
ENST00000336092.4
|
TNNI1
|
troponin I type 1 (skeletal, slow) |
| chr16_-_2004683 | 9.27 |
ENST00000268661.7
|
RPL3L
|
ribosomal protein L3-like |
| chr1_-_38471156 | 9.21 |
ENST00000373016.3
|
FHL3
|
four and a half LIM domains 3 |
| chr19_+_50706866 | 8.87 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
| chr2_+_170335924 | 8.81 |
ENST00000554017.1
ENST00000392663.2 ENST00000513963.1 |
BBS5
RP11-724O16.1
|
Bardet-Biedl syndrome 5 Bardet-Biedl syndrome 5 protein; Uncharacterized protein |
| chr18_+_11981427 | 8.77 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr5_+_78985673 | 8.75 |
ENST00000446378.2
|
CMYA5
|
cardiomyopathy associated 5 |
| chr2_+_239047337 | 8.33 |
ENST00000409223.1
ENST00000305959.4 |
KLHL30
|
kelch-like family member 30 |
| chr19_-_55658650 | 8.29 |
ENST00000589226.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr17_-_18161870 | 8.28 |
ENST00000579294.1
ENST00000545457.2 ENST00000379450.4 ENST00000578558.1 |
FLII
|
flightless I homolog (Drosophila) |
| chr19_-_2050852 | 8.27 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr22_+_19744226 | 8.04 |
ENST00000332710.4
ENST00000329705.7 ENST00000359500.3 |
TBX1
|
T-box 1 |
| chr19_-_2051223 | 7.89 |
ENST00000309340.7
ENST00000589534.1 ENST00000250896.3 ENST00000589509.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr1_-_9189144 | 7.79 |
ENST00000414642.2
|
GPR157
|
G protein-coupled receptor 157 |
| chr16_+_55357672 | 7.79 |
ENST00000290552.7
|
IRX6
|
iroquois homeobox 6 |
| chr16_+_29817841 | 7.76 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr11_-_47207950 | 7.72 |
ENST00000298838.6
ENST00000531226.1 ENST00000524509.1 ENST00000528201.1 ENST00000530513.1 |
PACSIN3
|
protein kinase C and casein kinase substrate in neurons 3 |
| chr10_+_11784360 | 7.68 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
| chrY_+_2803322 | 7.64 |
ENST00000383052.1
ENST00000155093.3 ENST00000449237.1 ENST00000443793.1 |
ZFY
|
zinc finger protein, Y-linked |
| chr17_+_4853442 | 7.62 |
ENST00000522301.1
|
ENO3
|
enolase 3 (beta, muscle) |
| chr13_+_113863858 | 7.57 |
ENST00000375440.4
|
CUL4A
|
cullin 4A |
| chr18_+_11981547 | 7.48 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr9_+_128509663 | 7.46 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr19_-_55658687 | 7.18 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr11_+_1861399 | 7.05 |
ENST00000381905.3
|
TNNI2
|
troponin I type 2 (skeletal, fast) |
| chr6_-_160114260 | 6.98 |
ENST00000367054.2
ENST00000367055.4 ENST00000444946.2 ENST00000452684.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr17_-_18162230 | 6.97 |
ENST00000327031.4
|
FLII
|
flightless I homolog (Drosophila) |
| chr1_+_78354175 | 6.91 |
ENST00000401035.3
ENST00000457030.1 ENST00000330010.8 |
NEXN
|
nexilin (F actin binding protein) |
| chr22_-_50700140 | 6.84 |
ENST00000215659.8
|
MAPK12
|
mitogen-activated protein kinase 12 |
| chr9_+_128509624 | 6.78 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr14_-_21566731 | 6.76 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr1_-_1850697 | 6.74 |
ENST00000378598.4
ENST00000416272.1 ENST00000310991.3 |
TMEM52
|
transmembrane protein 52 |
| chr12_+_54378923 | 6.73 |
ENST00000303460.4
|
HOXC10
|
homeobox C10 |
| chr11_-_17410629 | 6.72 |
ENST00000526912.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
| chr1_-_229569834 | 6.72 |
ENST00000366684.3
ENST00000366683.2 |
ACTA1
|
actin, alpha 1, skeletal muscle |
| chr20_-_60718430 | 6.63 |
ENST00000370873.4
ENST00000370858.3 |
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7 |
| chr8_-_145115584 | 6.60 |
ENST00000426825.1
|
OPLAH
|
5-oxoprolinase (ATP-hydrolysing) |
| chr2_+_241508039 | 6.52 |
ENST00000270357.4
|
RNPEPL1
|
arginyl aminopeptidase (aminopeptidase B)-like 1 |
| chr11_-_17410869 | 6.47 |
ENST00000528731.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
| chr7_-_139876812 | 6.36 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr10_+_123872483 | 6.31 |
ENST00000369001.1
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr11_-_14380664 | 6.27 |
ENST00000545643.1
ENST00000256196.4 |
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2 |
| chr6_-_100912785 | 6.27 |
ENST00000369208.3
|
SIM1
|
single-minded family bHLH transcription factor 1 |
| chr6_+_160769399 | 6.19 |
ENST00000392145.1
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
| chr1_+_31886653 | 6.15 |
ENST00000536384.1
|
SERINC2
|
serine incorporator 2 |
| chr6_+_41021027 | 6.09 |
ENST00000244669.2
|
APOBEC2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 |
| chr8_+_142402089 | 6.02 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
| chr19_-_55658281 | 6.01 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr1_+_78354243 | 6.01 |
ENST00000294624.8
|
NEXN
|
nexilin (F actin binding protein) |
| chr12_-_122907091 | 5.97 |
ENST00000358808.2
ENST00000361654.4 ENST00000539080.1 ENST00000537178.1 |
CLIP1
|
CAP-GLY domain containing linker protein 1 |
| chr1_+_17866290 | 5.96 |
ENST00000361221.3
ENST00000452522.1 ENST00000434513.1 |
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
| chr5_+_78365577 | 5.95 |
ENST00000518666.1
ENST00000521567.1 |
BHMT2
|
betaine--homocysteine S-methyltransferase 2 |
| chr3_-_185542761 | 5.89 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr5_-_133340326 | 5.86 |
ENST00000425992.1
ENST00000395044.3 ENST00000395047.2 |
VDAC1
|
voltage-dependent anion channel 1 |
| chr15_-_64338521 | 5.82 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
| chr12_+_54379569 | 5.80 |
ENST00000513209.1
|
RP11-834C11.12
|
RP11-834C11.12 |
| chr4_+_154387480 | 5.79 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
| chr7_-_139876734 | 5.78 |
ENST00000006967.5
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr20_+_57466461 | 5.74 |
ENST00000306090.10
|
GNAS
|
GNAS complex locus |
| chr19_+_7580944 | 5.69 |
ENST00000597229.1
|
ZNF358
|
zinc finger protein 358 |
| chr22_-_36018569 | 5.67 |
ENST00000419229.1
ENST00000406324.1 |
MB
|
myoglobin |
| chr12_+_133264156 | 5.64 |
ENST00000317479.3
ENST00000543589.1 |
PXMP2
|
peroxisomal membrane protein 2, 22kDa |
| chr6_+_133562472 | 5.61 |
ENST00000430974.2
ENST00000367895.5 ENST00000355167.3 ENST00000355286.6 |
EYA4
|
eyes absent homolog 4 (Drosophila) |
| chrX_+_153170189 | 5.59 |
ENST00000358927.2
|
AVPR2
|
arginine vasopressin receptor 2 |
| chr19_+_19174795 | 5.56 |
ENST00000318596.7
|
SLC25A42
|
solute carrier family 25, member 42 |
| chrX_+_153170455 | 5.53 |
ENST00000430697.1
ENST00000337474.5 ENST00000370049.1 |
AVPR2
|
arginine vasopressin receptor 2 |
| chr9_-_33402506 | 5.53 |
ENST00000377425.4
ENST00000537089.1 ENST00000297988.1 ENST00000539936.1 ENST00000541274.1 |
AQP7
|
aquaporin 7 |
| chr19_-_2041159 | 5.51 |
ENST00000589441.1
|
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chrY_-_284779 | 5.50 |
ENSTR0000381625.4
|
PPP2R3B
|
protein phosphatase 2, regulatory subunit B'', beta |
| chr6_+_111408698 | 5.48 |
ENST00000368851.5
|
SLC16A10
|
solute carrier family 16 (aromatic amino acid transporter), member 10 |
| chr3_-_71802760 | 5.46 |
ENST00000295612.3
|
EIF4E3
|
eukaryotic translation initiation factor 4E family member 3 |
| chr16_+_29817399 | 5.45 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr5_+_179247759 | 5.44 |
ENST00000389805.4
ENST00000504627.1 ENST00000402874.3 ENST00000510187.1 |
SQSTM1
|
sequestosome 1 |
| chr3_-_52488048 | 5.42 |
ENST00000232975.3
|
TNNC1
|
troponin C type 1 (slow) |
| chr6_-_105585022 | 5.41 |
ENST00000314641.5
|
BVES
|
blood vessel epicardial substance |
| chr1_+_2160134 | 5.40 |
ENST00000378536.4
|
SKI
|
v-ski avian sarcoma viral oncogene homolog |
| chr16_-_56459354 | 5.36 |
ENST00000290649.5
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase |
| chr10_-_30024716 | 5.34 |
ENST00000375398.2
ENST00000375400.3 |
SVIL
|
supervillin |
| chr11_-_3663480 | 5.31 |
ENST00000397068.3
|
ART5
|
ADP-ribosyltransferase 5 |
| chr3_+_171758344 | 5.31 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
| chr3_-_48130314 | 5.31 |
ENST00000439356.1
ENST00000395734.3 ENST00000426837.2 |
MAP4
|
microtubule-associated protein 4 |
| chr19_-_16582815 | 5.29 |
ENST00000455140.2
ENST00000248070.6 ENST00000594975.1 |
EPS15L1
|
epidermal growth factor receptor pathway substrate 15-like 1 |
| chr9_-_139581848 | 5.27 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr2_+_241375069 | 5.25 |
ENST00000264039.2
|
GPC1
|
glypican 1 |
| chr1_-_16344500 | 5.24 |
ENST00000406363.2
ENST00000411503.1 ENST00000545268.1 ENST00000487046.1 |
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular) |
| chr8_-_124553437 | 5.20 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
| chr11_-_47207390 | 5.20 |
ENST00000539589.1
ENST00000528462.1 |
PACSIN3
|
protein kinase C and casein kinase substrate in neurons 3 |
| chr9_-_139581875 | 5.18 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr1_+_31885963 | 5.15 |
ENST00000373709.3
|
SERINC2
|
serine incorporator 2 |
| chr17_+_4487816 | 5.13 |
ENST00000389313.4
|
SMTNL2
|
smoothelin-like 2 |
| chr10_-_13342051 | 5.12 |
ENST00000479604.1
|
PHYH
|
phytanoyl-CoA 2-hydroxylase |
| chr22_-_24951054 | 5.11 |
ENST00000447813.2
ENST00000402766.1 ENST00000407471.3 ENST00000435822.1 |
GUCD1
|
guanylyl cyclase domain containing 1 |
| chr19_-_46272462 | 5.10 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
| chr5_-_78365437 | 5.09 |
ENST00000380311.4
ENST00000540686.1 ENST00000255189.3 |
DMGDH
|
dimethylglycine dehydrogenase |
| chr19_-_18717627 | 5.09 |
ENST00000392386.3
|
CRLF1
|
cytokine receptor-like factor 1 |
| chr4_+_152330390 | 5.09 |
ENST00000503146.1
ENST00000435205.1 |
FAM160A1
|
family with sequence similarity 160, member A1 |
| chr17_+_72428218 | 5.08 |
ENST00000392628.2
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr4_+_77172847 | 5.06 |
ENST00000515604.1
ENST00000539752.1 ENST00000424749.2 |
FAM47E
FAM47E-STBD1
FAM47E
|
uncharacterized protein LOC100631383 FAM47E-STBD1 readthrough family with sequence similarity 47, member E |
| chr14_+_104029362 | 5.06 |
ENST00000495778.1
|
APOPT1
|
apoptogenic 1, mitochondrial |
| chr6_-_35656712 | 5.02 |
ENST00000357266.4
ENST00000542713.1 |
FKBP5
|
FK506 binding protein 5 |
| chr7_-_1595871 | 4.99 |
ENST00000319010.5
|
TMEM184A
|
transmembrane protein 184A |
| chrX_+_135229600 | 4.99 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr22_-_50699701 | 4.98 |
ENST00000395780.1
|
MAPK12
|
mitogen-activated protein kinase 12 |
| chr10_-_131762105 | 4.98 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
| chr2_+_103353367 | 4.95 |
ENST00000454536.1
ENST00000409528.1 ENST00000409173.1 |
TMEM182
|
transmembrane protein 182 |
| chrX_+_135229559 | 4.95 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
| chr9_-_114246635 | 4.93 |
ENST00000338205.5
|
KIAA0368
|
KIAA0368 |
| chr9_-_74979420 | 4.92 |
ENST00000343431.2
ENST00000376956.3 |
ZFAND5
|
zinc finger, AN1-type domain 5 |
| chr6_-_160114293 | 4.92 |
ENST00000337404.4
ENST00000538183.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr5_+_78365536 | 4.91 |
ENST00000255192.3
|
BHMT2
|
betaine--homocysteine S-methyltransferase 2 |
| chr5_-_1882858 | 4.90 |
ENST00000511126.1
ENST00000231357.2 |
IRX4
|
iroquois homeobox 4 |
| chr14_-_105635090 | 4.89 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
| chr11_+_1942580 | 4.89 |
ENST00000381558.1
|
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr11_-_47470703 | 4.88 |
ENST00000298854.2
|
RAPSN
|
receptor-associated protein of the synapse |
| chr11_-_57283159 | 4.84 |
ENST00000533263.1
ENST00000278426.3 |
SLC43A1
|
solute carrier family 43 (amino acid system L transporter), member 1 |
| chr22_-_24110063 | 4.84 |
ENST00000520222.1
ENST00000401675.3 |
CHCHD10
|
coiled-coil-helix-coiled-coil-helix domain containing 10 |
| chr11_+_109964087 | 4.84 |
ENST00000278590.3
|
ZC3H12C
|
zinc finger CCCH-type containing 12C |
| chr4_-_8160416 | 4.81 |
ENST00000505872.1
ENST00000447017.2 ENST00000341937.5 ENST00000361581.5 |
ABLIM2
|
actin binding LIM protein family, member 2 |
| chr6_+_17393839 | 4.81 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr17_+_4487294 | 4.77 |
ENST00000338859.4
|
SMTNL2
|
smoothelin-like 2 |
| chr10_-_735553 | 4.77 |
ENST00000280886.6
ENST00000423550.1 |
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
| chr4_+_76932375 | 4.76 |
ENST00000513122.1
|
ART3
|
ADP-ribosyltransferase 3 |
| chr12_-_10875831 | 4.73 |
ENST00000279550.7
ENST00000228251.4 |
YBX3
|
Y box binding protein 3 |
| chr12_-_33049690 | 4.72 |
ENST00000070846.6
ENST00000340811.4 |
PKP2
|
plakophilin 2 |
| chr14_+_104552016 | 4.71 |
ENST00000551177.1
ENST00000546892.2 ENST00000455920.2 |
ASPG
|
asparaginase homolog (S. cerevisiae) |
| chr1_-_9189229 | 4.70 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr20_+_13202418 | 4.70 |
ENST00000262487.4
|
ISM1
|
isthmin 1, angiogenesis inhibitor |
| chr1_+_78354330 | 4.70 |
ENST00000440324.1
|
NEXN
|
nexilin (F actin binding protein) |
| chr9_+_127539425 | 4.69 |
ENST00000331715.9
|
OLFML2A
|
olfactomedin-like 2A |
| chr9_-_114246332 | 4.68 |
ENST00000602978.1
|
KIAA0368
|
KIAA0368 |
| chr14_+_105266933 | 4.65 |
ENST00000555360.1
|
ZBTB42
|
zinc finger and BTB domain containing 42 |
| chr4_+_75311019 | 4.65 |
ENST00000502307.1
|
AREG
|
amphiregulin |
| chr12_+_54378849 | 4.64 |
ENST00000515593.1
|
HOXC10
|
homeobox C10 |
| chr11_+_818902 | 4.63 |
ENST00000336615.4
|
PNPLA2
|
patatin-like phospholipase domain containing 2 |
| chr16_+_89238149 | 4.63 |
ENST00000289746.2
|
CDH15
|
cadherin 15, type 1, M-cadherin (myotubule) |
| chr1_-_23751189 | 4.62 |
ENST00000374601.3
ENST00000450454.2 |
TCEA3
|
transcription elongation factor A (SII), 3 |
| chr3_-_185542817 | 4.62 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr6_-_146056341 | 4.61 |
ENST00000435470.1
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) |
| chrY_-_21239221 | 4.61 |
ENST00000447937.1
ENST00000331787.2 |
TTTY14
|
testis-specific transcript, Y-linked 14 (non-protein coding) |
| chr12_-_54982300 | 4.61 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr9_+_127539481 | 4.61 |
ENST00000373580.3
|
OLFML2A
|
olfactomedin-like 2A |
| chr12_+_3069037 | 4.58 |
ENST00000397122.2
|
TEAD4
|
TEA domain family member 4 |
| chr11_+_76494253 | 4.56 |
ENST00000333090.4
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
| chr6_+_17281802 | 4.56 |
ENST00000509686.1
|
RBM24
|
RNA binding motif protein 24 |
| chr17_-_1394940 | 4.55 |
ENST00000570984.2
ENST00000361007.2 |
MYO1C
|
myosin IC |
| chr5_-_138730817 | 4.55 |
ENST00000434752.2
|
PROB1
|
proline-rich basic protein 1 |
| chr6_-_105584560 | 4.55 |
ENST00000336775.5
|
BVES
|
blood vessel epicardial substance |
| chr20_+_5986756 | 4.55 |
ENST00000452938.1
|
CRLS1
|
cardiolipin synthase 1 |
| chr17_+_1182948 | 4.53 |
ENST00000333813.3
|
TUSC5
|
tumor suppressor candidate 5 |
| chr7_-_95225768 | 4.52 |
ENST00000005178.5
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4 |
| chrX_+_153046456 | 4.52 |
ENST00000393786.3
ENST00000370104.1 ENST00000370108.3 ENST00000370101.3 ENST00000430541.1 ENST00000370100.1 |
SRPK3
|
SRSF protein kinase 3 |
| chr1_-_40042416 | 4.52 |
ENST00000372857.3
ENST00000372856.3 ENST00000531243.2 ENST00000451091.2 |
PABPC4
|
poly(A) binding protein, cytoplasmic 4 (inducible form) |
| chr5_-_150460539 | 4.51 |
ENST00000520931.1
ENST00000520695.1 ENST00000521591.1 ENST00000518977.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr14_+_105886150 | 4.50 |
ENST00000331320.7
ENST00000406191.1 |
MTA1
|
metastasis associated 1 |
| chr4_+_75310851 | 4.49 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
| chr4_+_8271471 | 4.46 |
ENST00000307358.2
ENST00000382512.3 |
HTRA3
|
HtrA serine peptidase 3 |
| chr7_-_130418888 | 4.46 |
ENST00000310992.4
|
KLF14
|
Kruppel-like factor 14 |
| chr10_+_120789223 | 4.46 |
ENST00000425699.1
|
NANOS1
|
nanos homolog 1 (Drosophila) |
| chr5_+_148651409 | 4.45 |
ENST00000296721.4
|
AFAP1L1
|
actin filament associated protein 1-like 1 |
| chr19_+_16435625 | 4.45 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chr7_+_16685756 | 4.44 |
ENST00000415365.1
ENST00000258761.3 ENST00000433922.2 ENST00000452975.2 ENST00000405202.1 |
BZW2
|
basic leucine zipper and W2 domains 2 |
| chr15_-_55881135 | 4.44 |
ENST00000302000.6
|
PYGO1
|
pygopus family PHD finger 1 |
| chr1_-_119532127 | 4.43 |
ENST00000207157.3
|
TBX15
|
T-box 15 |
| chr11_-_3663502 | 4.43 |
ENST00000359918.4
|
ART5
|
ADP-ribosyltransferase 5 |
| chr6_-_160148356 | 4.43 |
ENST00000401980.3
ENST00000545162.1 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr6_+_133562744 | 4.43 |
ENST00000525849.1
|
EYA4
|
eyes absent homolog 4 (Drosophila) |
| chr1_-_201081579 | 4.42 |
ENST00000367338.3
ENST00000362061.3 |
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
| chr10_-_44880491 | 4.42 |
ENST00000374426.2
ENST00000395795.4 ENST00000395794.2 ENST00000374429.2 ENST00000395793.3 ENST00000343575.6 |
CXCL12
|
chemokine (C-X-C motif) ligand 12 |
| chr17_-_78428487 | 4.42 |
ENST00000562672.2
|
CTD-2526A2.2
|
CTD-2526A2.2 |
| chr16_+_56642489 | 4.40 |
ENST00000561491.1
|
MT2A
|
metallothionein 2A |
| chr9_+_32384617 | 4.39 |
ENST00000379923.1
ENST00000309951.6 ENST00000541043.1 |
ACO1
|
aconitase 1, soluble |
| chr1_-_19229248 | 4.38 |
ENST00000375341.3
|
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1 |
| chr5_+_148651469 | 4.37 |
ENST00000515000.1
|
AFAP1L1
|
actin filament associated protein 1-like 1 |
| chr11_-_63933504 | 4.35 |
ENST00000255681.6
|
MACROD1
|
MACRO domain containing 1 |
| chrX_-_153285395 | 4.35 |
ENST00000369980.3
|
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
| chr1_-_22263790 | 4.34 |
ENST00000374695.3
|
HSPG2
|
heparan sulfate proteoglycan 2 |
| chr1_+_16062820 | 4.34 |
ENST00000294454.5
|
SLC25A34
|
solute carrier family 25, member 34 |
| chr22_-_50699972 | 4.33 |
ENST00000395778.3
|
MAPK12
|
mitogen-activated protein kinase 12 |
| chr7_-_27213893 | 4.33 |
ENST00000283921.4
|
HOXA10
|
homeobox A10 |
| chr19_-_56056888 | 4.33 |
ENST00000592464.1
ENST00000420723.3 |
SBK3
|
SH3 domain binding kinase family, member 3 |
| chr17_-_62050278 | 4.33 |
ENST00000578147.1
ENST00000435607.1 |
SCN4A
|
sodium channel, voltage-gated, type IV, alpha subunit |
| chr2_+_119981384 | 4.32 |
ENST00000393108.2
ENST00000354888.5 ENST00000450943.2 ENST00000393110.2 ENST00000393106.2 ENST00000409811.1 ENST00000393107.2 |
STEAP3
|
STEAP family member 3, metalloreductase |
| chr9_-_130635741 | 4.32 |
ENST00000223836.10
|
AK1
|
adenylate kinase 1 |
| chr11_+_1944054 | 4.30 |
ENST00000397301.1
ENST00000397304.2 ENST00000446240.1 |
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr4_+_87928353 | 4.30 |
ENST00000511722.1
|
AFF1
|
AF4/FMR2 family, member 1 |
| chrX_-_153285251 | 4.30 |
ENST00000444230.1
ENST00000393682.1 ENST00000393687.2 ENST00000429936.2 ENST00000369974.2 |
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
| chr17_+_45608430 | 4.29 |
ENST00000322157.4
|
NPEPPS
|
aminopeptidase puromycin sensitive |
| chr18_+_77155942 | 4.29 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
| chr6_-_160147925 | 4.29 |
ENST00000535561.1
|
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr9_+_137218362 | 4.28 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
| chr9_-_114245938 | 4.28 |
ENST00000602447.1
|
KIAA0368
|
KIAA0368 |
| chr13_-_76056250 | 4.27 |
ENST00000377636.3
ENST00000431480.2 ENST00000377625.2 ENST00000425511.1 |
TBC1D4
|
TBC1 domain family, member 4 |
| chr5_+_148521454 | 4.27 |
ENST00000508983.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr10_-_13342097 | 4.27 |
ENST00000263038.4
|
PHYH
|
phytanoyl-CoA 2-hydroxylase |
| chr17_+_79679369 | 4.26 |
ENST00000350690.5
|
SLC25A10
|
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
| chr7_+_97910962 | 4.26 |
ENST00000539286.1
|
BRI3
|
brain protein I3 |
| chr3_-_12705600 | 4.26 |
ENST00000542177.1
ENST00000442415.2 ENST00000251849.4 |
RAF1
|
v-raf-1 murine leukemia viral oncogene homolog 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF711_TFAP2A_TFAP2D
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.1 | 18.4 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 4.2 | 4.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 4.1 | 20.6 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 4.0 | 11.9 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 4.0 | 11.9 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 3.9 | 34.9 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 3.5 | 10.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
| 3.4 | 17.1 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 3.3 | 10.0 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 3.3 | 10.0 | GO:0015709 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 3.2 | 9.7 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 3.0 | 3.0 | GO:0071711 | basement membrane organization(GO:0071711) |
| 2.9 | 14.5 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 2.8 | 14.1 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 2.7 | 10.8 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 2.7 | 2.7 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 2.7 | 2.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 2.7 | 8.0 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 2.6 | 10.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 2.6 | 7.9 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 2.6 | 2.6 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
| 2.6 | 2.6 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) |
| 2.6 | 10.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 2.6 | 15.5 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 2.6 | 7.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 2.5 | 7.6 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 2.5 | 7.5 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 2.5 | 7.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 2.5 | 22.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 2.4 | 2.4 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
| 2.4 | 14.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 2.4 | 7.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 2.3 | 9.2 | GO:1903060 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 2.3 | 9.0 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 2.2 | 11.2 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 2.2 | 11.2 | GO:0015862 | uridine transport(GO:0015862) |
| 2.2 | 17.8 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 2.2 | 4.4 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 2.2 | 17.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 2.2 | 6.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 2.2 | 6.5 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
| 2.2 | 2.2 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 2.2 | 6.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 2.2 | 15.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 2.1 | 6.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 2.1 | 14.9 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 2.1 | 6.3 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 2.1 | 8.4 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 2.1 | 10.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 2.1 | 6.3 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 2.1 | 6.2 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 2.1 | 4.1 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 2.1 | 6.2 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 2.0 | 18.4 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 2.0 | 8.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 2.0 | 5.9 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 2.0 | 9.8 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.9 | 9.7 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 1.9 | 5.8 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.9 | 9.7 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 1.9 | 5.8 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 1.9 | 7.5 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.9 | 7.4 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 1.9 | 3.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 1.8 | 7.4 | GO:0044691 | tooth eruption(GO:0044691) |
| 1.8 | 7.4 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 1.8 | 9.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 1.8 | 7.3 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 1.8 | 7.1 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 1.8 | 5.3 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 1.8 | 7.1 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.8 | 5.3 | GO:0035349 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 1.8 | 7.1 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 1.8 | 5.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 1.7 | 19.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 1.7 | 5.2 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 1.7 | 11.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 1.7 | 1.7 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 1.7 | 5.1 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.7 | 10.1 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.7 | 10.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.7 | 6.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 1.7 | 8.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.7 | 6.6 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 1.6 | 8.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 1.6 | 6.4 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 1.6 | 14.4 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 1.6 | 7.8 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 1.6 | 7.8 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 1.6 | 6.2 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) cellular response to vitamin E(GO:0071306) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.5 | 6.2 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 1.5 | 7.7 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 1.5 | 9.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 1.5 | 3.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 1.5 | 4.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.5 | 9.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 1.5 | 24.3 | GO:0000050 | urea cycle(GO:0000050) |
| 1.5 | 6.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 1.5 | 10.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.5 | 11.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.5 | 1.5 | GO:0060179 | male mating behavior(GO:0060179) |
| 1.5 | 4.4 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 1.5 | 4.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 1.5 | 5.8 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 1.4 | 5.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 1.4 | 5.8 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 1.4 | 4.3 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.4 | 5.7 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 1.4 | 5.7 | GO:0015911 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) plasma membrane long-chain fatty acid transport(GO:0015911) |
| 1.4 | 4.2 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 1.4 | 7.0 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.4 | 7.0 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 1.4 | 89.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 1.4 | 8.4 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 1.4 | 1.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 1.4 | 4.2 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 1.4 | 7.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 1.4 | 6.9 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 1.4 | 22.0 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.4 | 4.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.4 | 5.5 | GO:0009386 | translational attenuation(GO:0009386) |
| 1.4 | 1.4 | GO:0031033 | myosin filament organization(GO:0031033) |
| 1.4 | 8.2 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 1.4 | 4.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 1.4 | 4.1 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 1.4 | 1.4 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 1.4 | 5.4 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.4 | 5.4 | GO:0002384 | hepatic immune response(GO:0002384) |
| 1.4 | 8.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 1.4 | 6.8 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 1.3 | 6.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.3 | 2.7 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 1.3 | 2.7 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 1.3 | 25.4 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
| 1.3 | 19.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.3 | 9.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 1.3 | 1.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 1.3 | 14.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.3 | 3.9 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 1.3 | 5.2 | GO:1905044 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 1.3 | 2.6 | GO:0070781 | response to biotin(GO:0070781) |
| 1.3 | 1.3 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 1.3 | 7.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 1.3 | 5.2 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
| 1.3 | 5.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 1.3 | 2.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.3 | 2.6 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 1.3 | 7.7 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 1.3 | 9.0 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 1.3 | 9.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 1.3 | 10.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.3 | 3.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 1.3 | 3.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 1.3 | 3.8 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 1.3 | 3.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 1.3 | 7.6 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 1.3 | 1.3 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 1.3 | 8.9 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
| 1.3 | 6.3 | GO:0097017 | renal protein absorption(GO:0097017) |
| 1.3 | 17.7 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 1.3 | 6.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 1.3 | 5.0 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 1.3 | 10.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 1.3 | 5.0 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 1.3 | 3.8 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 1.2 | 6.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 1.2 | 7.5 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 1.2 | 3.7 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 1.2 | 8.6 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 1.2 | 3.7 | GO:1990036 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 1.2 | 2.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 1.2 | 17.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 1.2 | 4.9 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 1.2 | 14.5 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 1.2 | 6.0 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 1.2 | 3.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 1.2 | 3.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 1.2 | 6.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 1.2 | 2.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 1.2 | 3.6 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 1.2 | 1.2 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 1.2 | 3.5 | GO:0003192 | mitral valve formation(GO:0003192) |
| 1.2 | 3.5 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.2 | 1.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 1.2 | 3.5 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.2 | 5.8 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 1.2 | 17.4 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 1.2 | 8.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 1.1 | 5.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 1.1 | 10.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.1 | 3.4 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 1.1 | 4.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.1 | 3.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 1.1 | 6.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.1 | 1.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 1.1 | 6.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 1.1 | 2.2 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 1.1 | 9.0 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 1.1 | 8.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 1.1 | 24.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 1.1 | 4.5 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.1 | 13.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 1.1 | 10.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 1.1 | 6.6 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 1.1 | 4.4 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 1.1 | 2.2 | GO:0010324 | membrane invagination(GO:0010324) |
| 1.1 | 9.9 | GO:1903276 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 1.1 | 5.5 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 1.1 | 3.3 | GO:0071262 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 1.1 | 8.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 1.1 | 3.3 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.1 | 2.2 | GO:0072014 | proximal tubule development(GO:0072014) |
| 1.1 | 4.3 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 1.1 | 3.3 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 1.1 | 14.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 1.1 | 5.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.1 | 3.2 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
| 1.1 | 7.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 1.1 | 1.1 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 1.1 | 12.8 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 1.1 | 3.2 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 1.1 | 3.2 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 1.1 | 5.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 1.1 | 1.1 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
| 1.1 | 2.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 1.1 | 2.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 1.1 | 7.4 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.1 | 6.3 | GO:0001757 | somite specification(GO:0001757) |
| 1.1 | 5.3 | GO:0008050 | female courtship behavior(GO:0008050) |
| 1.1 | 45.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 1.0 | 3.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 1.0 | 3.1 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 1.0 | 4.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.0 | 3.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 1.0 | 2.1 | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 1.0 | 3.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 1.0 | 5.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.0 | 4.1 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 1.0 | 5.2 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
| 1.0 | 6.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 1.0 | 1.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 1.0 | 13.4 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 1.0 | 3.1 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 1.0 | 5.1 | GO:0033590 | response to cobalamin(GO:0033590) |
| 1.0 | 4.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 1.0 | 4.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 1.0 | 2.0 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 1.0 | 4.1 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 1.0 | 8.2 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 1.0 | 26.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 1.0 | 3.0 | GO:0044209 | AMP salvage(GO:0044209) |
| 1.0 | 80.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 1.0 | 27.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 1.0 | 4.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 1.0 | 4.0 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 1.0 | 11.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 1.0 | 5.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.0 | 4.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 1.0 | 3.0 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 1.0 | 1.0 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
| 1.0 | 4.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 1.0 | 3.0 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 1.0 | 5.0 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 1.0 | 1.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 1.0 | 6.0 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 1.0 | 6.0 | GO:0021539 | subthalamus development(GO:0021539) |
| 1.0 | 6.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 1.0 | 5.9 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 1.0 | 14.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 1.0 | 5.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 1.0 | 1.0 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
| 1.0 | 8.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 1.0 | 3.9 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 1.0 | 5.9 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 1.0 | 1.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 1.0 | 5.8 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.0 | 1.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 1.0 | 1.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 1.0 | 2.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.0 | 2.9 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 1.0 | 2.9 | GO:0060691 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
| 1.0 | 4.8 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.9 | 6.6 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.9 | 17.0 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.9 | 7.6 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.9 | 7.6 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.9 | 2.8 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.9 | 6.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.9 | 3.8 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.9 | 3.8 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.9 | 2.8 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.9 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.9 | 5.6 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 0.9 | 2.8 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.9 | 5.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.9 | 0.9 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.9 | 3.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.9 | 5.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.9 | 3.7 | GO:1905229 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.9 | 7.4 | GO:0046618 | drug export(GO:0046618) |
| 0.9 | 4.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.9 | 3.7 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.9 | 6.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.9 | 1.8 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.9 | 3.6 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.9 | 3.6 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.9 | 9.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.9 | 1.8 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.9 | 0.9 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
| 0.9 | 1.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.9 | 18.2 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.9 | 1.8 | GO:0015817 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.9 | 4.5 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.9 | 9.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.9 | 2.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.9 | 16.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.9 | 8.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.9 | 1.8 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.9 | 13.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.9 | 2.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.9 | 8.0 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.9 | 3.5 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.9 | 4.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.9 | 7.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.9 | 2.6 | GO:0032618 | interleukin-15 production(GO:0032618) |
| 0.9 | 4.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.9 | 9.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.9 | 3.5 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.9 | 2.6 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.9 | 18.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.9 | 2.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.9 | 2.6 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.9 | 0.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.9 | 5.2 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.9 | 2.6 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.9 | 2.6 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.9 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.9 | 2.6 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.9 | 5.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.9 | 4.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.9 | 1.7 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.8 | 3.4 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.8 | 9.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.8 | 9.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.8 | 1.7 | GO:0034250 | positive regulation of cellular amide metabolic process(GO:0034250) |
| 0.8 | 12.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.8 | 16.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.8 | 0.8 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.8 | 4.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.8 | 2.5 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
| 0.8 | 3.4 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.8 | 1.7 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.8 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.8 | 1.7 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 0.8 | 1.7 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.8 | 6.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.8 | 0.8 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.8 | 2.5 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.8 | 5.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.8 | 0.8 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.8 | 2.5 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.8 | 4.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.8 | 4.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.8 | 4.9 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.8 | 1.6 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.8 | 0.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.8 | 11.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.8 | 2.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.8 | 7.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.8 | 3.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.8 | 0.8 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.8 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.8 | 2.4 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.8 | 4.0 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.8 | 1.6 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.8 | 10.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.8 | 11.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.8 | 2.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.8 | 2.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
| 0.8 | 2.4 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.8 | 4.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.8 | 14.3 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.8 | 1.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.8 | 4.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.8 | 16.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.8 | 2.4 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.8 | 8.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.8 | 112.9 | GO:0006415 | translational termination(GO:0006415) |
| 0.8 | 0.8 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) |
| 0.8 | 3.9 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.8 | 4.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.8 | 14.9 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.8 | 2.4 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
| 0.8 | 4.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.8 | 1.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.8 | 1.6 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.8 | 3.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.8 | 4.7 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.8 | 1.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.8 | 0.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.8 | 2.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.8 | 2.3 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.8 | 8.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.8 | 0.8 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
| 0.8 | 0.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.8 | 20.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.8 | 4.6 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
| 0.8 | 6.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.8 | 22.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.8 | 3.1 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.8 | 11.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.8 | 11.5 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.8 | 9.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.8 | 6.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.8 | 9.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.8 | 1.5 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.8 | 6.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.8 | 7.6 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.8 | 7.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.8 | 3.0 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.8 | 4.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.8 | 1.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.8 | 1.5 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.8 | 15.1 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.8 | 6.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.7 | 3.0 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.7 | 4.5 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.7 | 2.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.7 | 4.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.7 | 1.5 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
| 0.7 | 2.2 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
| 0.7 | 2.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.7 | 4.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.7 | 10.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.7 | 5.9 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.7 | 3.0 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.7 | 8.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.7 | 1.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.7 | 2.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.7 | 27.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.7 | 3.7 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.7 | 2.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.7 | 3.6 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.7 | 2.2 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.7 | 5.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.7 | 4.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.7 | 6.5 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.7 | 5.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.7 | 2.2 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.7 | 20.2 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.7 | 7.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.7 | 0.7 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 0.7 | 3.6 | GO:0060717 | chorion development(GO:0060717) |
| 0.7 | 30.0 | GO:0042407 | cristae formation(GO:0042407) |
| 0.7 | 1.4 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.7 | 5.7 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.7 | 3.5 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.7 | 0.7 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.7 | 4.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.7 | 2.1 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.7 | 2.8 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.7 | 15.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.7 | 0.7 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.7 | 2.1 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
| 0.7 | 0.7 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.7 | 1.4 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
| 0.7 | 3.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.7 | 17.5 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.7 | 0.7 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.7 | 2.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.7 | 48.2 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.7 | 0.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.7 | 1.4 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.7 | 0.7 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.7 | 0.7 | GO:0031497 | chromatin assembly(GO:0031497) |
| 0.7 | 2.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.7 | 1.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
| 0.7 | 0.7 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.7 | 11.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.7 | 4.8 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.7 | 6.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.7 | 0.7 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.7 | 64.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.7 | 4.8 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.7 | 2.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.7 | 2.0 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.7 | 1.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.7 | 1.4 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.7 | 3.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.7 | 4.1 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.7 | 17.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.7 | 62.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.7 | 3.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.7 | 4.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.7 | 2.0 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.7 | 0.7 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.7 | 11.4 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.7 | 2.0 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.7 | 2.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.7 | 3.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.7 | 7.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.7 | 0.7 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
| 0.7 | 6.6 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.7 | 6.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.7 | 5.3 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.7 | 7.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.7 | 9.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.7 | 5.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.7 | 2.0 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.7 | 0.7 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.7 | 2.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.7 | 1.3 | GO:0036475 | neuron death in response to oxidative stress(GO:0036475) |
| 0.7 | 2.0 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.7 | 2.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
| 0.7 | 33.2 | GO:0005977 | glycogen metabolic process(GO:0005977) |
| 0.7 | 9.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.6 | 4.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.6 | 0.6 | GO:0001974 | blood vessel remodeling(GO:0001974) |
| 0.6 | 25.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.6 | 17.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
| 0.6 | 0.6 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.6 | 3.2 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.6 | 1.9 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.6 | 7.7 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.6 | 1.3 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.6 | 7.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.6 | 1.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.6 | 1.9 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.6 | 5.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.6 | 5.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.6 | 16.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.6 | 6.4 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.6 | 1.3 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.6 | 19.1 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.6 | 5.1 | GO:0030578 | PML body organization(GO:0030578) |
| 0.6 | 25.3 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
| 0.6 | 16.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.6 | 23.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.6 | 1.9 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.6 | 24.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.6 | 0.6 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.6 | 1.9 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.6 | 15.0 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.6 | 1.9 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.6 | 1.2 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.6 | 6.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.6 | 5.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.6 | 6.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.6 | 3.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.6 | 2.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.6 | 2.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.6 | 7.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.6 | 1.9 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.6 | 3.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.6 | 4.3 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.6 | 0.6 | GO:0046102 | adenosine catabolic process(GO:0006154) inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
| 0.6 | 0.6 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 0.6 | 11.7 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.6 | 9.8 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
| 0.6 | 1.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.6 | 3.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.6 | 1.8 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.6 | 1.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.6 | 6.1 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.6 | 4.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.6 | 13.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.6 | 1.8 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.6 | 7.9 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.6 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.6 | 0.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.6 | 3.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.6 | 2.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.6 | 2.4 | GO:0051836 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.6 | 4.8 | GO:0046324 | regulation of glucose import(GO:0046324) |
| 0.6 | 2.4 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.6 | 4.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.6 | 10.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.6 | 6.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.6 | 2.4 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
| 0.6 | 0.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.6 | 3.0 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
| 0.6 | 3.6 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.6 | 1.2 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
| 0.6 | 3.0 | GO:0008354 | germ cell migration(GO:0008354) |
| 0.6 | 7.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.6 | 7.8 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.6 | 9.0 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.6 | 3.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.6 | 3.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.6 | 4.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.6 | 3.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.6 | 1.8 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.6 | 10.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.6 | 4.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
| 0.6 | 3.6 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.6 | 3.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.6 | 5.3 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 0.6 | 3.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.6 | 1.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.6 | 1.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.6 | 4.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.6 | 10.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.6 | 1.2 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.6 | 13.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.6 | 15.9 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.6 | 2.4 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.6 | 1.8 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.6 | 2.9 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.6 | 2.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.6 | 2.4 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.6 | 2.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.6 | 5.3 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.6 | 17.6 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.6 | 3.5 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.6 | 1.2 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.6 | 2.3 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.6 | 2.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.6 | 5.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.6 | 3.5 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.6 | 7.5 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.6 | 4.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.6 | 1.7 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 0.6 | 3.5 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) positive regulation of ribosome biogenesis(GO:0090070) regulation of rRNA processing(GO:2000232) positive regulation of rRNA processing(GO:2000234) |
| 0.6 | 2.9 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.6 | 6.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.6 | 8.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.6 | 9.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.6 | 2.9 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.6 | 2.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.6 | 27.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.6 | 5.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.6 | 5.1 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) |
| 0.6 | 1.1 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 0.6 | 1.1 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.6 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.6 | 4.5 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.6 | 2.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.6 | 1.7 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.6 | 2.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.6 | 8.5 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.6 | 8.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.6 | 3.4 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.6 | 1.7 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.6 | 1.1 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
| 0.6 | 1.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.6 | 0.6 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 0.6 | 3.4 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.6 | 2.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.6 | 1.7 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.6 | 5.0 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.6 | 1.7 | GO:0035573 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.6 | 5.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.6 | 4.5 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.6 | 6.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.6 | 4.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.6 | 3.9 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.6 | 3.9 | GO:0060356 | leucine import(GO:0060356) |
| 0.6 | 0.6 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.5 | 3.8 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.5 | 1.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.5 | 3.3 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 0.5 | 2.7 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.5 | 2.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 | 1.6 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.5 | 3.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.5 | 1.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.5 | 1.6 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.5 | 3.3 | GO:0030242 | pexophagy(GO:0030242) |
| 0.5 | 1.6 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
| 0.5 | 6.0 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.5 | 2.2 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 0.5 | 1.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.5 | 0.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.5 | 2.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.5 | 1.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.5 | 11.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.5 | 2.2 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 0.5 | 2.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.5 | 3.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.5 | 3.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.5 | 1.1 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.5 | 3.8 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.5 | 2.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.5 | 14.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.5 | 3.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.5 | 4.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.5 | 2.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.5 | 11.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.5 | 1.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.5 | 1.6 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.5 | 3.7 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.5 | 0.5 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 0.5 | 0.5 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
| 0.5 | 0.5 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.5 | 24.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.5 | 0.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.5 | 5.3 | GO:0000303 | response to superoxide(GO:0000303) |
| 0.5 | 2.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.5 | 10.0 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.5 | 0.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.5 | 7.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.5 | 0.5 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
| 0.5 | 3.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 | 2.6 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.5 | 5.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.5 | 2.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.5 | 3.6 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.5 | 1.0 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.5 | 0.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.5 | 1.0 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.5 | 2.6 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
| 0.5 | 2.1 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.5 | 2.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.5 | 8.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.5 | 5.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.5 | 3.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.5 | 1.6 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.5 | 1.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.5 | 1.0 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.5 | 1.0 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.5 | 13.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.5 | 3.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.5 | 9.8 | GO:0008228 | opsonization(GO:0008228) |
| 0.5 | 9.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.5 | 2.6 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.5 | 3.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.5 | 1.0 | GO:0002605 | negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
| 0.5 | 1.5 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.5 | 3.6 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.5 | 1.5 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.5 | 0.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.5 | 0.5 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.5 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 | 6.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.5 | 0.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.5 | 1.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.5 | 1.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.5 | 1.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.5 | 2.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.5 | 1.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
| 0.5 | 1.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.5 | 3.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.5 | 0.5 | GO:0099541 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
| 0.5 | 1.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.5 | 3.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.5 | 15.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.5 | 3.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.5 | 1.0 | GO:0032105 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
| 0.5 | 2.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.5 | 8.5 | GO:0072189 | ureter development(GO:0072189) |
| 0.5 | 0.5 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.5 | 1.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.5 | 1.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.5 | 5.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.5 | 1.5 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.5 | 5.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.5 | 1.0 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.5 | 5.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.5 | 0.5 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.5 | 6.4 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.5 | 4.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.5 | 2.4 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.5 | 1.0 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.5 | 1.9 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.5 | 1.0 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
| 0.5 | 6.3 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.5 | 1.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.5 | 2.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.5 | 0.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.5 | 6.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.5 | 0.5 | GO:0035907 | dorsal aorta development(GO:0035907) |
| 0.5 | 57.2 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
| 0.5 | 1.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.5 | 1.4 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.5 | 1.9 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.5 | 4.3 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
| 0.5 | 1.4 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
| 0.5 | 1.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.5 | 4.3 | GO:0060613 | fat pad development(GO:0060613) |
| 0.5 | 2.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.5 | 1.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.5 | 18.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.5 | 1.4 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.5 | 4.7 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.5 | 0.9 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.5 | 5.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.5 | 0.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.5 | 1.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 | 2.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 0.5 | 16.9 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.5 | 0.9 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.5 | 6.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.5 | 6.5 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.5 | 0.9 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.5 | 1.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.5 | 4.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.5 | 0.5 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.5 | 4.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.5 | 2.8 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.5 | 7.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.5 | 3.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.5 | 1.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.5 | 6.5 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.5 | 1.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.5 | 7.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.5 | 1.4 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.5 | 1.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.5 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.5 | 0.5 | GO:0014889 | muscle atrophy(GO:0014889) |
| 0.5 | 6.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.5 | 2.3 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.5 | 2.8 | GO:0006863 | purine nucleobase transport(GO:0006863) adenine transport(GO:0015853) |
| 0.5 | 56.8 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.5 | 0.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.5 | 1.8 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.5 | 3.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.5 | 0.5 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
| 0.5 | 2.3 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.5 | 6.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.5 | 4.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.5 | 2.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.5 | 5.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.5 | 0.5 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
| 0.5 | 12.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.5 | 0.9 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.4 | 1.3 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.4 | 4.9 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.4 | 2.7 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.4 | 1.3 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.4 | 0.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.4 | 7.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.4 | 5.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.4 | 0.9 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
| 0.4 | 2.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.4 | 52.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.4 | 0.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.4 | 1.3 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.4 | 1.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 | 1.8 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.4 | 6.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.4 | 8.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
| 0.4 | 3.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.4 | 5.7 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.4 | 0.4 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.4 | 2.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.4 | 6.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.4 | 2.2 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.4 | 1.7 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.4 | 11.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.4 | 3.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.4 | 2.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.4 | 2.6 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.4 | 1.7 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.4 | 2.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.4 | 4.2 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.4 | 0.4 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.4 | 1.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.4 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.4 | 1.7 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.4 | 2.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.4 | 1.3 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.4 | 3.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.4 | 2.1 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA import into nucleus(GO:0061015) |
| 0.4 | 0.4 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.4 | 10.9 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.4 | 1.7 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.4 | 1.7 | GO:0002572 | pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.4 | 2.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.4 | 14.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.4 | 4.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.4 | 1.2 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.4 | 13.6 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.4 | 1.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.4 | 3.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.4 | 1.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.4 | 2.5 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.4 | 1.2 | GO:0003183 | mitral valve morphogenesis(GO:0003183) |
| 0.4 | 0.4 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
| 0.4 | 0.8 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.4 | 13.1 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.4 | 2.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.4 | 1.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.4 | 1.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.4 | 1.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.4 | 1.6 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.4 | 2.8 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.4 | 1.6 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.4 | 2.8 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.4 | 6.0 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.4 | 7.2 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.4 | 3.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.4 | 1.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.4 | 3.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 2.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.4 | 5.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.4 | 2.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 | 1.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.4 | 2.0 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.4 | 1.6 | GO:0018277 | protein deamination(GO:0018277) |
| 0.4 | 1.2 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
| 0.4 | 2.8 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.4 | 0.4 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.4 | 3.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.4 | 3.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.4 | 0.4 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
| 0.4 | 3.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.4 | 3.9 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.4 | 0.4 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.4 | 1.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.4 | 10.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.4 | 3.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.4 | 2.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 | 2.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.4 | 1.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 0.4 | 1.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.4 | 13.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.4 | 5.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.4 | 8.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.4 | 17.4 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.4 | 3.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.4 | 4.6 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
| 0.4 | 5.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.4 | 1.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.4 | 3.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.4 | 4.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.4 | 1.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.4 | 0.4 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
| 0.4 | 27.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.4 | 0.4 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.4 | 4.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.4 | 0.8 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
| 0.4 | 1.1 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.4 | 1.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.4 | 2.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.4 | 3.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.4 | 3.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.4 | 1.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.4 | 2.6 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.4 | 0.4 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.4 | 2.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.4 | 16.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.4 | 6.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.4 | 3.4 | GO:0015074 | DNA integration(GO:0015074) |
| 0.4 | 3.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.4 | 3.4 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.4 | 49.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.4 | 13.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.4 | 4.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.4 | 3.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
| 0.4 | 1.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.4 | 1.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.4 | 3.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.4 | 13.7 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.4 | 1.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.4 | 4.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.4 | 6.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.4 | 3.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.4 | 1.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.4 | 0.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.4 | 0.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.4 | 5.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.4 | 1.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.4 | 3.3 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.4 | 0.4 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.4 | 0.7 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.4 | 4.0 | GO:0060065 | uterus development(GO:0060065) |
| 0.4 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.4 | 4.0 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.4 | 4.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.4 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.4 | 8.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.4 | 1.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.4 | 2.9 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.4 | 1.1 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.4 | 2.9 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.4 | 1.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.4 | 1.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.4 | 2.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 | 0.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.4 | 1.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.4 | 1.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.4 | 1.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.4 | 3.2 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.4 | 1.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.4 | 0.7 | GO:1902946 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.4 | 1.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.4 | 1.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 | 0.4 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
| 0.4 | 12.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.4 | 1.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.4 | 2.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.4 | 3.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.4 | 4.9 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.4 | 0.4 | GO:0034371 | chylomicron remodeling(GO:0034371) |
| 0.4 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.4 | 3.5 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.4 | 1.4 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.4 | 3.9 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
| 0.4 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.4 | 2.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 | 1.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.4 | 1.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.3 | 2.4 | GO:0001519 | peptide amidation(GO:0001519) peptide modification(GO:0031179) |
| 0.3 | 10.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.3 | 0.7 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.3 | 1.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.3 | 3.8 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.3 | 4.9 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.3 | 0.3 | GO:0021915 | neural tube development(GO:0021915) |
| 0.3 | 1.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.3 | 0.3 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
| 0.3 | 1.7 | GO:0033274 | response to vitamin B2(GO:0033274) chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.3 | 2.4 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.3 | 1.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.3 | 5.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.3 | 1.4 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.3 | 2.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 | 1.0 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.3 | 1.0 | GO:0030238 | male sex determination(GO:0030238) |
| 0.3 | 3.4 | GO:0060022 | hard palate development(GO:0060022) |
| 0.3 | 0.7 | GO:0050931 | pigment cell differentiation(GO:0050931) |
| 0.3 | 1.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.3 | 2.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.3 | 3.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.3 | 2.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.3 | 3.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.3 | 0.7 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.3 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.3 | 2.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.3 | 0.3 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.3 | 33.5 | GO:0006413 | translational initiation(GO:0006413) |
| 0.3 | 1.0 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.3 | 8.4 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.3 | 2.0 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.3 | 6.0 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.3 | 5.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.3 | 0.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.3 | 2.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.3 | 0.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.3 | 1.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.3 | 1.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.3 | 1.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 | 1.0 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 0.3 | 2.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.3 | 1.3 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.3 | 1.0 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
| 0.3 | 0.7 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 0.3 | 3.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.3 | 1.0 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.3 | 2.3 | GO:0034773 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
| 0.3 | 0.7 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.3 | 3.3 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.3 | 1.0 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.3 | 0.7 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
| 0.3 | 0.7 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.3 | 1.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.3 | 2.9 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.3 | 4.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.3 | 1.0 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.3 | 0.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.3 | 3.2 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.3 | 2.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.3 | 1.0 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.3 | 21.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.3 | 2.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.3 | 2.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.3 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 | 7.0 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.3 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 | 1.0 | GO:0033122 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.3 | 0.3 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.3 | 14.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.3 | 2.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.3 | 0.6 | GO:0016458 | gene silencing(GO:0016458) |
| 0.3 | 1.3 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.3 | 2.5 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.3 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 | 1.3 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
| 0.3 | 1.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.3 | 2.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.3 | 1.2 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.3 | 1.9 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.3 | 1.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.3 | 0.6 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
| 0.3 | 1.2 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.3 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 | 0.3 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.3 | 2.2 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.3 | 1.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.3 | 0.6 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 | 4.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.3 | 3.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.3 | 0.3 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
| 0.3 | 1.5 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.3 | 1.8 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.3 | 0.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 | 1.8 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.3 | 5.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.3 | 0.9 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.3 | 0.9 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.3 | 3.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.3 | 3.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.3 | 0.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.3 | 1.8 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.3 | 0.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.3 | 0.3 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.3 | 3.0 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.3 | 8.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.3 | 1.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.3 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.3 | 2.7 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.3 | 1.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.3 | 3.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.3 | 0.3 | GO:0060525 | branching involved in prostate gland morphogenesis(GO:0060442) prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.3 | 1.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 | 0.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.3 | 1.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.3 | 0.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.3 | 1.7 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
| 0.3 | 1.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.3 | 1.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.3 | 1.2 | GO:1900426 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) positive regulation of defense response to bacterium(GO:1900426) |
| 0.3 | 0.9 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.3 | 1.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.3 | 0.9 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.3 | 2.9 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.3 | 0.9 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.3 | 2.6 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.3 | 1.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.3 | 4.9 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
| 0.3 | 4.0 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.3 | 0.6 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.3 | 0.9 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.3 | 4.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.3 | 1.4 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.3 | 2.8 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
| 0.3 | 3.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 | 3.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.3 | 2.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 | 3.4 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 | 5.3 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.3 | 10.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.3 | 1.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.3 | 10.8 | GO:0051031 | tRNA transport(GO:0051031) |
| 0.3 | 4.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.3 | 0.3 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 0.3 | 2.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 0.3 | 1.4 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.3 | 0.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.3 | 0.6 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.3 | 0.8 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.3 | 1.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.3 | 1.4 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.3 | 0.3 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.3 | 1.1 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
| 0.3 | 1.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.3 | 0.5 | GO:0007497 | posterior midgut development(GO:0007497) |
| 0.3 | 0.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.3 | 7.3 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
| 0.3 | 1.6 | GO:0007512 | adult heart development(GO:0007512) |
| 0.3 | 1.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 | 0.8 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.3 | 8.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.3 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.3 | 1.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.3 | 7.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.3 | 0.3 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 | 1.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 | 12.6 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.3 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.3 | 0.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.3 | 7.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.3 | 0.3 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.3 | 5.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.3 | 1.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 | 8.9 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.3 | 2.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.3 | 1.6 | GO:0002003 | angiotensin maturation(GO:0002003) |
| 0.3 | 1.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 | 1.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.3 | 0.8 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.3 | 3.7 | GO:0015747 | urate transport(GO:0015747) |
| 0.3 | 0.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.3 | 2.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.3 | 0.8 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.3 | 6.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.3 | 1.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.3 | 1.3 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.3 | 1.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.3 | 9.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.3 | 1.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.3 | 1.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.3 | 0.5 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.3 | 2.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
| 0.3 | 1.0 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.3 | 0.8 | GO:0001944 | vasculature development(GO:0001944) |
| 0.3 | 1.0 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.3 | 4.6 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
| 0.3 | 2.8 | GO:0051147 | regulation of muscle cell differentiation(GO:0051147) |
| 0.3 | 2.3 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.3 | 1.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.3 | 19.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.3 | 3.5 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.3 | 1.3 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
| 0.3 | 1.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 1.2 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.2 | 1.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.2 | 0.5 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.2 | 0.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 | 3.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.2 | 0.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
| 0.2 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 | 6.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.2 | 3.2 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.2 | 3.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.2 | 0.5 | GO:0060789 | hair follicle placode formation(GO:0060789) |
| 0.2 | 0.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.2 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 1.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.2 | 1.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.2 | 0.2 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.2 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 | 1.7 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.2 | 1.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 | 1.0 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
| 0.2 | 1.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.2 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.2 | 5.2 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
| 0.2 | 1.4 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.2 | 1.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 | 2.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 | 0.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 | 0.2 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 0.2 | 0.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 | 0.7 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.2 | 1.9 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.2 | 1.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.2 | 1.6 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.2 | 0.9 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.2 | 0.2 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
| 0.2 | 0.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 0.2 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 0.2 | 3.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.2 | 3.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.2 | 0.2 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
| 0.2 | 0.5 | GO:0046649 | lymphocyte activation(GO:0046649) |
| 0.2 | 0.9 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 1.4 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 | 7.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.2 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.2 | 0.7 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.2 | 1.1 | GO:1903971 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.2 | 1.6 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.2 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 0.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.2 | 0.7 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.2 | 0.7 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.2 | 0.7 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
| 0.2 | 12.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 | 0.9 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 1.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.2 | 7.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.2 | 1.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.2 | 1.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.2 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.2 | 1.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.2 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
| 0.2 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.2 | 0.2 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.2 | 0.7 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.2 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 0.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 0.9 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.2 | 10.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.2 | 8.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 | 0.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.2 | 1.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.2 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.2 | 2.6 | GO:0030638 | glycoside metabolic process(GO:0016137) polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 | 1.5 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
| 0.2 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.2 | 5.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.2 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.2 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.2 | 2.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.2 | 1.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.2 | 7.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.2 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.2 | 0.6 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
| 0.2 | 0.6 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.2 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.2 | 2.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 | 0.8 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.2 | 2.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 | 4.1 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 | 1.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.2 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.2 | 0.6 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 | 7.6 | GO:0001885 | endothelial cell development(GO:0001885) |
| 0.2 | 1.6 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.2 | 1.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.2 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
| 0.2 | 0.6 | GO:0015822 | ornithine transport(GO:0015822) |
| 0.2 | 0.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.2 | 25.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.2 | 1.0 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.2 | 0.8 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.2 | 0.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.2 | 1.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.2 | 0.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.2 | 0.6 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.2 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.2 | 3.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 | 1.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.2 | 1.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 | 1.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.2 | 0.4 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.2 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.2 | 0.6 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 | 0.4 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 0.2 | 0.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.2 | 0.2 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.2 | 4.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 | 1.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.2 | 1.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 | 0.2 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 | 0.4 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.2 | 2.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.2 | 0.6 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.2 | 0.6 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.2 | 0.4 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.2 | 0.6 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.2 | 0.8 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.2 | 0.6 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.2 | 1.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.2 | 1.7 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.2 | 1.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 | 0.2 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.2 | 0.6 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.2 | 0.6 | GO:1990000 | amyloid fibril formation(GO:1990000) |
| 0.2 | 0.6 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.2 | 2.9 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.2 | 1.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.2 | 0.2 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.2 | 0.8 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.2 | 0.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.2 | 1.9 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.2 | 2.1 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.2 | 0.6 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.2 | 0.4 | GO:1904587 | response to glycoprotein(GO:1904587) |
| 0.2 | 3.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.2 | 2.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.2 | 0.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.2 | 1.5 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
| 0.2 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 4.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.2 | 0.6 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.2 | 1.1 | GO:0007379 | segment specification(GO:0007379) |
| 0.2 | 1.7 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 4.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.2 | 2.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 | 1.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 | 0.9 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 | 5.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 2.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.2 | 1.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.2 | 0.7 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.2 | 5.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 0.9 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.2 | 1.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.2 | 3.3 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.2 | 7.4 | GO:0006414 | translational elongation(GO:0006414) |
| 0.2 | 0.4 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 9.2 | GO:0007032 | endosome organization(GO:0007032) |
| 0.2 | 1.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.2 | 8.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.2 | 0.5 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.2 | 0.4 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
| 0.2 | 1.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.2 | 3.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
| 0.2 | 1.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 | 0.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.2 | 13.1 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.2 | 0.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.2 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.2 | 1.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 | 1.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 | 8.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 | 0.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.2 | 2.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.2 | 0.7 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.2 | 5.5 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.2 | 0.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.2 | 2.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.2 | 4.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.2 | 2.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.2 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 | 3.4 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 1.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.2 | 2.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 | 0.8 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
| 0.2 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.2 | 1.5 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.2 | 2.9 | GO:0097435 | fibril organization(GO:0097435) |
| 0.2 | 1.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.2 | 1.3 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.2 | 0.8 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.2 | 1.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 0.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.2 | 3.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.2 | 2.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.2 | 2.8 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.2 | 5.0 | GO:1901998 | toxin transport(GO:1901998) |
| 0.2 | 2.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.2 | 1.3 | GO:0015867 | ATP transport(GO:0015867) |
| 0.2 | 0.7 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.2 | 0.2 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
| 0.2 | 1.3 | GO:0016246 | RNA interference(GO:0016246) |
| 0.2 | 0.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.2 | 0.5 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.2 | 11.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.2 | 3.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.2 | 2.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 | 0.2 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.2 | 0.2 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
| 0.2 | 1.0 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
| 0.2 | 1.0 | GO:0019395 | fatty acid oxidation(GO:0019395) |
| 0.2 | 0.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.2 | 0.8 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.2 | 0.2 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
| 0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.2 | 1.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.2 | 0.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 0.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 1.6 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.2 | 4.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 2.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.2 | 0.8 | GO:0030047 | actin modification(GO:0030047) |
| 0.2 | 2.4 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.2 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.2 | 2.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.2 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.2 | 1.1 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 0.9 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.1 | 0.1 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 | 0.7 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 | 0.7 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
| 0.1 | 0.6 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 1.0 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 | 0.3 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.1 | 2.9 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
| 0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.1 | 2.8 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.1 | 0.3 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.1 | 2.5 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 1.6 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.1 | 0.1 | GO:1901374 | acetate ester transport(GO:1901374) |
| 0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 | 3.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.1 | 3.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.1 | 0.1 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.1 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.1 | 0.6 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.1 | 1.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 1.0 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 0.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 | 0.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.1 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.1 | 0.7 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
| 0.1 | 1.5 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
| 0.1 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 1.0 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.1 | 8.9 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.1 | 0.3 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 | 0.4 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.1 | 1.2 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 1.4 | GO:1903578 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
| 0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
| 0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.1 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
| 0.1 | 0.5 | GO:0018126 | protein hydroxylation(GO:0018126) |
| 0.1 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 1.9 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
| 0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.1 | 0.4 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.1 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
| 0.1 | 0.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 | 2.9 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.1 | 5.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.1 | 0.3 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
| 0.1 | 1.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.1 | 0.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 0.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 | 19.5 | GO:0007517 | muscle organ development(GO:0007517) |
| 0.1 | 1.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.1 | 0.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 | 0.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 0.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 1.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 1.2 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 0.3 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.1 | 0.5 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
| 0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.1 | 0.9 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 0.4 | GO:1902116 | negative regulation of cilium assembly(GO:1902018) negative regulation of organelle assembly(GO:1902116) |
| 0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.6 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 0.1 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 | 0.4 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 0.1 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.1 | 9.4 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 | 0.7 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.1 | 0.6 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.1 | 0.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 3.3 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.1 | 0.5 | GO:0031647 | regulation of protein stability(GO:0031647) |
| 0.1 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) |
| 0.1 | 0.9 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 0.2 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.1 | 17.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 | 0.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 0.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.1 | 0.3 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 0.1 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 | 0.2 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 | 0.7 | GO:0031638 | zymogen activation(GO:0031638) |
| 0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.1 | 2.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.1 | 0.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.1 | 0.2 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.1 | 0.7 | GO:0003158 | endothelium development(GO:0003158) |
| 0.1 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
| 0.1 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 0.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 0.1 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 0.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.1 | 0.3 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 | 2.9 | GO:0006399 | tRNA metabolic process(GO:0006399) |
| 0.1 | 0.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.1 | 4.1 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 | 0.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.1 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 | 0.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) glucosamine catabolic process(GO:0006043) |
| 0.1 | 0.3 | GO:0001840 | neural plate development(GO:0001840) |
| 0.1 | 0.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
| 0.1 | 1.0 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
| 0.1 | 2.1 | GO:0006067 | ethanol metabolic process(GO:0006067) |
| 0.1 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
| 0.1 | 0.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.1 | 0.7 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
| 0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.1 | 2.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 | 0.3 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
| 0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 1.9 | GO:0016573 | histone acetylation(GO:0016573) |
| 0.1 | 0.5 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
| 0.1 | 0.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 1.2 | GO:0019827 | stem cell population maintenance(GO:0019827) |
| 0.1 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.1 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 | 6.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
| 0.1 | 1.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 3.7 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
| 0.1 | 0.5 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
| 0.1 | 0.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 0.3 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
| 0.1 | 0.3 | GO:0048341 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
| 0.1 | 2.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.5 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
| 0.1 | 4.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.1 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.1 | 0.1 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 | 2.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 0.3 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.1 | 0.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.1 | 2.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 3.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 0.1 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.1 | 1.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.1 | 0.3 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 0.5 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 0.6 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 0.5 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 0.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 1.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.8 | GO:0051607 | defense response to virus(GO:0051607) |
| 0.1 | 0.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.1 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 2.1 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.1 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 2.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.1 | GO:0070231 | T cell apoptotic process(GO:0070231) |
| 0.1 | 0.2 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.1 | 0.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.1 | 0.2 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.1 | 0.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.1 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.5 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.1 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 | 0.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.1 | 0.2 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
| 0.1 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.1 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 0.1 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 0.2 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
| 0.1 | 0.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.1 | 0.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.1 | 1.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 0.3 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
| 0.1 | 0.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.1 | 0.1 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
| 0.1 | 0.1 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 | 1.3 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.1 | 0.2 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
| 0.1 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 1.2 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
| 0.1 | 0.4 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 0.6 | GO:0045333 | cellular respiration(GO:0045333) |
| 0.1 | 0.1 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.1 | 0.3 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 | 0.2 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.1 | 0.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 | 0.2 | GO:0034329 | cell junction assembly(GO:0034329) |
| 0.1 | 0.4 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
| 0.1 | 0.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.1 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 0.8 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.1 | 0.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 | 1.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.1 | 0.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
| 0.0 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.0 | 0.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.0 | 0.9 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 0.0 | 0.4 | GO:0017145 | stem cell division(GO:0017145) |
| 0.0 | 0.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 | 1.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
| 0.0 | 0.6 | GO:1904353 | regulation of telomere capping(GO:1904353) |
| 0.0 | 0.3 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 | 0.7 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 | 0.0 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.0 | 0.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.0 | 0.1 | GO:2001188 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) |
| 0.0 | 0.4 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.0 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
| 0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.0 | 0.2 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 | 0.5 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 0.3 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 0.0 | 0.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.0 | 0.2 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
| 0.0 | 0.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
| 0.0 | 0.2 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.1 | GO:0000423 | macromitophagy(GO:0000423) |
| 0.0 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 0.2 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
| 0.0 | 0.1 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
| 0.0 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.0 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.5 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.0 | 0.0 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
| 0.0 | 0.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 | 0.2 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 0.6 | GO:0071378 | cellular response to growth hormone stimulus(GO:0071378) |
| 0.0 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.1 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.0 | 0.0 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 | 0.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
| 0.0 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.0 | 0.0 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.0 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.4 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.0 | 0.2 | GO:0098901 | regulation of cardiac muscle cell action potential(GO:0098901) |
| 0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 0.0 | 0.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 | 0.0 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
| 0.0 | 0.0 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 | 0.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.0 | 0.6 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 | 0.0 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.0 | 0.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
| 0.0 | 0.0 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.0 | 1.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.0 | 0.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 1.3 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.0 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 0.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 1.2 | GO:0016125 | sterol metabolic process(GO:0016125) |
| 0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 | 1.5 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.0 | 0.0 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
| 0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.0 | 0.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.0 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 | 0.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
| 0.0 | 0.0 | GO:0007549 | dosage compensation(GO:0007549) |
| 0.0 | 0.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.0 | 0.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.0 | 0.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.0 | 0.0 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
| 0.0 | 0.0 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
| 0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 | 0.0 | GO:0030282 | bone mineralization(GO:0030282) |
| 0.0 | 0.1 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.0 | 0.1 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 | 0.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 0.0 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
| 0.0 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
| 0.0 | 0.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.0 | 1.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 91.1 | GO:0005861 | troponin complex(GO:0005861) |
| 2.6 | 7.8 | GO:0030689 | Noc complex(GO:0030689) |
| 2.5 | 10.1 | GO:0045160 | myosin I complex(GO:0045160) |
| 2.4 | 21.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 2.3 | 9.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 2.2 | 10.9 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 2.1 | 8.2 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 1.9 | 5.7 | GO:0005745 | m-AAA complex(GO:0005745) |
| 1.8 | 14.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 1.8 | 8.8 | GO:0032449 | CBM complex(GO:0032449) |
| 1.7 | 10.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 1.6 | 9.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 1.5 | 10.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 1.5 | 9.0 | GO:0097513 | myosin II filament(GO:0097513) |
| 1.5 | 10.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 1.5 | 5.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 1.4 | 12.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 1.4 | 7.0 | GO:0002133 | polycystin complex(GO:0002133) |
| 1.4 | 9.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.4 | 9.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 1.4 | 6.9 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 1.4 | 1.4 | GO:1990246 | uniplex complex(GO:1990246) |
| 1.3 | 12.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 1.3 | 7.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 1.3 | 3.9 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 1.3 | 6.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.3 | 7.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 1.3 | 9.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 1.3 | 14.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 1.2 | 3.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.2 | 9.8 | GO:0031415 | NatA complex(GO:0031415) |
| 1.2 | 3.6 | GO:0034657 | GID complex(GO:0034657) |
| 1.2 | 3.6 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 1.2 | 9.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 1.2 | 3.6 | GO:0008623 | CHRAC(GO:0008623) |
| 1.2 | 4.6 | GO:0044753 | amphisome(GO:0044753) |
| 1.1 | 3.4 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 1.1 | 4.6 | GO:0070552 | BRISC complex(GO:0070552) |
| 1.1 | 5.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 1.1 | 6.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 1.1 | 3.3 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 1.1 | 15.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 1.1 | 3.2 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
| 1.1 | 11.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 1.1 | 17.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 1.1 | 5.3 | GO:1903349 | omegasome membrane(GO:1903349) |
| 1.1 | 10.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 1.1 | 71.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 1.0 | 6.3 | GO:0071797 | LUBAC complex(GO:0071797) |
| 1.0 | 16.7 | GO:0031931 | TORC1 complex(GO:0031931) |
| 1.0 | 2.1 | GO:0032797 | SMN complex(GO:0032797) |
| 1.0 | 3.1 | GO:1990032 | parallel fiber(GO:1990032) |
| 1.0 | 15.5 | GO:0097470 | ribbon synapse(GO:0097470) |
| 1.0 | 12.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 1.0 | 15.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 1.0 | 13.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 1.0 | 8.0 | GO:1990393 | 3M complex(GO:1990393) |
| 1.0 | 4.0 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 1.0 | 59.7 | GO:0043034 | costamere(GO:0043034) |
| 1.0 | 5.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 1.0 | 2.9 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 1.0 | 1.0 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 1.0 | 5.7 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.9 | 4.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.9 | 25.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.9 | 31.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.9 | 16.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.9 | 2.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.9 | 6.4 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
| 0.9 | 8.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.9 | 9.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.9 | 6.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.9 | 1.8 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.9 | 2.7 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.9 | 8.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.9 | 2.6 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.9 | 26.1 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.9 | 4.4 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.9 | 2.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.9 | 11.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.9 | 22.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.9 | 6.0 | GO:0034448 | EGO complex(GO:0034448) |
| 0.9 | 6.0 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.9 | 23.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.9 | 17.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.9 | 63.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.8 | 5.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.8 | 5.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.8 | 7.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.8 | 12.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.8 | 8.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.8 | 4.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.8 | 52.8 | GO:0031430 | M band(GO:0031430) |
| 0.8 | 5.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.8 | 5.7 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.8 | 12.9 | GO:0032039 | integrator complex(GO:0032039) |
| 0.8 | 2.4 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.8 | 24.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.8 | 25.3 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.8 | 13.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.8 | 6.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.8 | 6.2 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.8 | 1.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.8 | 2.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.8 | 0.8 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.8 | 7.7 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.8 | 3.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.8 | 7.7 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.8 | 13.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.8 | 2.3 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.8 | 55.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.8 | 3.8 | GO:0071942 | XPC complex(GO:0071942) |
| 0.7 | 6.0 | GO:0097361 | CIA complex(GO:0097361) |
| 0.7 | 3.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.7 | 20.8 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.7 | 10.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.7 | 2.2 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.7 | 0.7 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.7 | 2.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.7 | 7.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.7 | 1.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.7 | 3.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.7 | 2.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.7 | 3.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.7 | 2.8 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.7 | 12.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.7 | 4.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.7 | 0.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.7 | 16.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.7 | 7.0 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.7 | 4.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.7 | 2.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.7 | 11.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.7 | 4.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.7 | 6.3 | GO:0044754 | autolysosome(GO:0044754) |
| 0.7 | 14.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.7 | 5.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.7 | 3.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.7 | 2.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.7 | 0.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.7 | 2.1 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.7 | 3.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.7 | 9.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.7 | 9.5 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.7 | 1.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.7 | 6.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.7 | 336.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.7 | 6.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.7 | 6.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.7 | 7.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.7 | 1.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.7 | 142.7 | GO:0031674 | I band(GO:0031674) |
| 0.7 | 3.3 | GO:0000938 | GARP complex(GO:0000938) |
| 0.6 | 3.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.6 | 7.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.6 | 1.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.6 | 4.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.6 | 8.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.6 | 13.7 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.6 | 29.0 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.6 | 47.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.6 | 6.8 | GO:0033503 | HULC complex(GO:0033503) |
| 0.6 | 3.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.6 | 1.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.6 | 6.1 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.6 | 9.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.6 | 69.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.6 | 2.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
| 0.6 | 1.8 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.6 | 30.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.6 | 39.4 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.6 | 8.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.6 | 13.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.6 | 1.7 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.6 | 0.6 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.6 | 9.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.6 | 14.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.6 | 16.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.6 | 2.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.6 | 10.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.6 | 5.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.6 | 2.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.5 | 15.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.5 | 3.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.5 | 1.6 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.5 | 1.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
| 0.5 | 4.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.5 | 1.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.5 | 7.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.5 | 1.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.5 | 2.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.5 | 1.6 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.5 | 7.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.5 | 4.7 | GO:0046930 | pore complex(GO:0046930) |
| 0.5 | 1.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.5 | 3.1 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.5 | 9.8 | GO:0005844 | polysome(GO:0005844) |
| 0.5 | 35.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.5 | 4.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.5 | 13.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.5 | 1.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.5 | 2.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.5 | 7.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.5 | 38.7 | GO:0030016 | myofibril(GO:0030016) |
| 0.5 | 1.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.5 | 5.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.5 | 9.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
| 0.5 | 1.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.5 | 4.9 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.5 | 7.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.5 | 6.7 | GO:0034464 | BBSome(GO:0034464) |
| 0.5 | 9.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.5 | 2.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.5 | 1.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.5 | 1.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.5 | 8.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.5 | 1.9 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.5 | 0.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.5 | 3.8 | GO:0001740 | Barr body(GO:0001740) |
| 0.5 | 4.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.5 | 7.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.5 | 4.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.5 | 3.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.5 | 35.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.5 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
| 0.5 | 64.8 | GO:0005604 | basement membrane(GO:0005604) |
| 0.5 | 2.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.5 | 10.1 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.5 | 5.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.4 | 8.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.4 | 8.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.4 | 11.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.4 | 3.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.4 | 73.0 | GO:0016605 | PML body(GO:0016605) |
| 0.4 | 5.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.4 | 0.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.4 | 1.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.4 | 14.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.4 | 12.0 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.4 | 3.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 28.9 | GO:0016235 | aggresome(GO:0016235) |
| 0.4 | 7.6 | GO:0045180 | basal cortex(GO:0045180) |
| 0.4 | 1.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.4 | 2.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.4 | 9.2 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.4 | 2.9 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.4 | 2.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.4 | 1.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.4 | 2.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.4 | 0.4 | GO:0000785 | chromatin(GO:0000785) |
| 0.4 | 2.4 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.4 | 10.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.4 | 2.4 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.4 | 0.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.4 | 1.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.4 | 4.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.4 | 4.6 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.4 | 15.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.4 | 0.4 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.4 | 17.4 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.4 | 5.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.4 | 3.8 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.4 | 6.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.4 | 10.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.4 | 107.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.4 | 1.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.4 | 2.2 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.4 | 10.3 | GO:0030315 | T-tubule(GO:0030315) |
| 0.4 | 25.6 | GO:0005776 | autophagosome(GO:0005776) |
| 0.4 | 70.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.4 | 8.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.4 | 7.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.4 | 33.1 | GO:0005901 | caveola(GO:0005901) |
| 0.4 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
| 0.4 | 23.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.4 | 4.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.4 | 1.4 | GO:0031251 | PAN complex(GO:0031251) |
| 0.3 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.3 | 1.4 | GO:0001652 | granular component(GO:0001652) |
| 0.3 | 0.3 | GO:0005713 | recombination nodule(GO:0005713) |
| 0.3 | 2.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.3 | 3.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.3 | 1.0 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.3 | 1.4 | GO:0005712 | chiasma(GO:0005712) |
| 0.3 | 0.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.3 | 5.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.3 | 5.8 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.3 | 2.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.3 | 4.4 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.3 | 4.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.3 | 2.7 | GO:0030478 | actin cap(GO:0030478) |
| 0.3 | 2.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 4.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.3 | 1.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.3 | 3.0 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.3 | 1.0 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.3 | 2.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.3 | 0.6 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.3 | 5.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.3 | 9.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.3 | 54.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.3 | 9.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.3 | 0.9 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.3 | 2.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.3 | 1.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.3 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.3 | 30.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.3 | 3.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.3 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.3 | 1.8 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.3 | 7.0 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.3 | 1.2 | GO:0019867 | outer membrane(GO:0019867) |
| 0.3 | 1.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.3 | 4.5 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.3 | 2.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.3 | 3.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.3 | 1.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.3 | 31.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.3 | 1.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.3 | 6.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.3 | 2.9 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.3 | 6.1 | GO:0071437 | invadopodium(GO:0071437) |
| 0.3 | 4.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.3 | 0.9 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.3 | 2.9 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.3 | 0.9 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.3 | 1.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.3 | 3.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.3 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 4.5 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.3 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.3 | 1.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.3 | 2.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 1.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.3 | 9.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.3 | 11.4 | GO:0016592 | mediator complex(GO:0016592) |
| 0.3 | 7.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.3 | 1.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.3 | 87.4 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.3 | 1.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.3 | 3.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.3 | 9.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.3 | 1.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.3 | 43.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.3 | 1.1 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.3 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.3 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 2.9 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.3 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 4.7 | GO:0036452 | ESCRT I complex(GO:0000813) ESCRT complex(GO:0036452) |
| 0.3 | 2.4 | GO:0043196 | varicosity(GO:0043196) |
| 0.3 | 1.8 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.3 | 1.6 | GO:0043219 | lateral loop(GO:0043219) |
| 0.3 | 1.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
| 0.3 | 2.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.3 | 4.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.3 | 38.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.3 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
| 0.3 | 8.4 | GO:0005840 | ribosome(GO:0005840) |
| 0.3 | 3.8 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.3 | 26.0 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.3 | 8.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.3 | 313.0 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.3 | 1.0 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.2 | 12.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.2 | 37.3 | GO:0005903 | brush border(GO:0005903) |
| 0.2 | 1.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.2 | 5.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 2.7 | GO:0008305 | integrin complex(GO:0008305) |
| 0.2 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.2 | 1.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 0.5 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 0.2 | 2.6 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.2 | 4.5 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.2 | 4.5 | GO:0030904 | retromer complex(GO:0030904) |
| 0.2 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.2 | 2.8 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.2 | 1.4 | GO:0032021 | NELF complex(GO:0032021) |
| 0.2 | 6.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.2 | 11.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.2 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 3.2 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 0.9 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 1.6 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.2 | 2.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 3.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.2 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.2 | 3.4 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 0.7 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.2 | 1.3 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.2 | 63.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.2 | 1.1 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.2 | 2.2 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 4.9 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.2 | 2.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.2 | 0.8 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
| 0.2 | 1.0 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.2 | 0.8 | GO:0060091 | kinocilium(GO:0060091) |
| 0.2 | 1.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 23.5 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.2 | 0.8 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.2 | 22.9 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.2 | 0.2 | GO:1902911 | protein kinase complex(GO:1902911) |
| 0.2 | 2.3 | GO:0072487 | MSL complex(GO:0072487) |
| 0.2 | 1.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.2 | 4.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.2 | 1.3 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.2 | 2.6 | GO:0042555 | MCM complex(GO:0042555) |
| 0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 1.5 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.2 | 2.6 | GO:0002102 | podosome(GO:0002102) |
| 0.2 | 0.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.2 | 1.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.2 | 10.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.2 | 1.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 2.1 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 0.9 | GO:0036019 | endolysosome(GO:0036019) |
| 0.2 | 1.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.2 | 8.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.2 | 0.7 | GO:0098559 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.2 | 567.3 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.2 | 1.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.2 | 0.7 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.2 | 1.0 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 1.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.2 | 1.9 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.2 | 0.6 | GO:0043292 | contractile fiber(GO:0043292) |
| 0.2 | 5.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 0.8 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.2 | 0.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.2 | 42.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 0.3 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
| 0.1 | 46.5 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.5 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.1 | 0.4 | GO:0036029 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.1 | 0.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.1 | 13.0 | GO:0070160 | occluding junction(GO:0070160) |
| 0.1 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 0.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.1 | 0.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 43.1 | GO:0005730 | nucleolus(GO:0005730) |
| 0.1 | 2.3 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 1.8 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 0.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 2.8 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.1 | 4.6 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 3.3 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.1 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
| 0.1 | 0.2 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.8 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.1 | 3.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 4.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 2.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 0.6 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 19.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 4.4 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 0.3 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.1 | 3.0 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 2.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 1.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 1.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 10.9 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 116.7 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.1 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 3.8 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.0 | 0.6 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 2.1 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.8 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.0 | 0.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
| 0.0 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.0 | 0.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.0 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
| 0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.6 | 13.7 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 4.3 | 17.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 4.0 | 56.6 | GO:0031014 | troponin T binding(GO:0031014) |
| 4.0 | 4.0 | GO:0050693 | LBD domain binding(GO:0050693) |
| 3.8 | 11.5 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 3.7 | 11.2 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 3.7 | 11.1 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 3.3 | 10.0 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 3.2 | 12.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 2.8 | 11.4 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 2.6 | 21.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 2.6 | 7.9 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 2.6 | 23.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 2.5 | 7.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 2.5 | 7.5 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 2.4 | 7.3 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 2.4 | 19.5 | GO:0035473 | lipase binding(GO:0035473) |
| 2.4 | 9.6 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 2.4 | 9.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 2.3 | 7.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 2.3 | 6.9 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 2.3 | 11.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 2.3 | 2.3 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 2.2 | 22.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 2.1 | 8.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 2.1 | 6.2 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 2.1 | 8.2 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 2.0 | 18.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 2.0 | 8.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 2.0 | 12.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 2.0 | 18.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 2.0 | 7.8 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 1.9 | 5.8 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 1.9 | 5.8 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.9 | 5.8 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 1.9 | 5.7 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 1.9 | 1.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 1.9 | 5.7 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 1.9 | 7.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 1.9 | 5.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 1.9 | 5.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.9 | 5.6 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 1.9 | 7.4 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.9 | 7.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.8 | 5.4 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 1.8 | 5.3 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 1.8 | 12.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 1.8 | 7.0 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 1.7 | 8.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 1.7 | 5.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 1.7 | 6.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 1.7 | 1.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 1.7 | 8.5 | GO:0010736 | serum response element binding(GO:0010736) |
| 1.7 | 5.1 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 1.7 | 5.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.7 | 6.7 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 1.7 | 3.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.6 | 16.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 1.6 | 4.9 | GO:0070984 | SET domain binding(GO:0070984) |
| 1.6 | 4.9 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 1.6 | 6.4 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 1.6 | 3.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 1.6 | 6.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 1.6 | 7.8 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 1.6 | 7.8 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 1.6 | 9.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 1.5 | 6.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 1.5 | 7.7 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 1.5 | 9.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 1.5 | 4.5 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 1.5 | 14.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 1.4 | 1.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 1.4 | 7.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 1.4 | 4.3 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 1.4 | 4.2 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 1.4 | 4.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 1.4 | 4.2 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 1.4 | 8.4 | GO:0070905 | serine binding(GO:0070905) |
| 1.4 | 9.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.4 | 8.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 1.4 | 4.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 1.4 | 6.9 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 1.4 | 19.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 1.4 | 4.1 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 1.3 | 8.0 | GO:0051373 | FATZ binding(GO:0051373) |
| 1.3 | 5.3 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 1.3 | 4.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 1.3 | 1.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 1.3 | 10.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 1.3 | 3.9 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 1.3 | 3.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 1.3 | 13.0 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 1.3 | 14.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 1.3 | 13.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 1.3 | 3.9 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 1.3 | 6.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 1.3 | 5.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 1.3 | 9.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 1.3 | 3.8 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 1.3 | 1.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.3 | 3.8 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 1.3 | 6.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 1.3 | 11.4 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 1.3 | 16.4 | GO:0015288 | porin activity(GO:0015288) |
| 1.3 | 13.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 1.3 | 3.8 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 1.2 | 5.0 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 1.2 | 7.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 1.2 | 1.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 1.2 | 31.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 1.2 | 3.7 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 1.2 | 31.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 1.2 | 14.9 | GO:0008142 | oxysterol binding(GO:0008142) |
| 1.2 | 11.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 1.2 | 6.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 1.2 | 14.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 1.2 | 11.0 | GO:0043426 | MRF binding(GO:0043426) |
| 1.2 | 6.1 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 1.2 | 4.9 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 1.2 | 4.9 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 1.2 | 4.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 1.2 | 3.6 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 1.2 | 6.0 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 1.2 | 8.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 1.2 | 4.8 | GO:0004803 | transposase activity(GO:0004803) |
| 1.2 | 3.6 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 1.2 | 10.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 1.2 | 10.4 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 1.2 | 5.8 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 1.2 | 9.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 1.1 | 3.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 1.1 | 10.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 1.1 | 3.4 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 1.1 | 15.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 1.1 | 34.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 1.1 | 5.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.1 | 5.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 1.1 | 4.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 1.1 | 2.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 1.1 | 5.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 1.1 | 6.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.1 | 4.3 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 1.1 | 3.2 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 1.1 | 23.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 1.1 | 2.1 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
| 1.1 | 4.3 | GO:0035939 | microsatellite binding(GO:0035939) |
| 1.1 | 15.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 1.0 | 23.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 1.0 | 3.1 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 1.0 | 13.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 1.0 | 2.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 1.0 | 4.1 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 1.0 | 3.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 1.0 | 5.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 1.0 | 3.1 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 1.0 | 14.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 1.0 | 5.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 1.0 | 9.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 1.0 | 8.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 1.0 | 3.0 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 1.0 | 3.0 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 1.0 | 6.9 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 1.0 | 20.7 | GO:0031432 | titin binding(GO:0031432) |
| 1.0 | 2.9 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 1.0 | 4.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 1.0 | 8.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 1.0 | 2.9 | GO:0030395 | lactose binding(GO:0030395) |
| 1.0 | 3.9 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 1.0 | 3.9 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 1.0 | 3.9 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 1.0 | 5.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 1.0 | 9.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.0 | 3.9 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 1.0 | 3.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 1.0 | 6.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 1.0 | 4.8 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 1.0 | 5.7 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 1.0 | 8.6 | GO:0032810 | sterol response element binding(GO:0032810) |
| 1.0 | 1.9 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.9 | 2.8 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.9 | 7.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.9 | 3.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.9 | 3.8 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.9 | 2.8 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.9 | 5.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.9 | 2.8 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.9 | 9.3 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.9 | 2.8 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.9 | 5.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.9 | 7.3 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.9 | 2.8 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.9 | 2.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.9 | 1.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.9 | 2.7 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.9 | 6.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.9 | 6.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.9 | 6.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.9 | 6.3 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.9 | 6.2 | GO:0004519 | endonuclease activity(GO:0004519) |
| 0.9 | 7.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.9 | 3.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.9 | 8.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.9 | 9.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.9 | 6.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.9 | 7.8 | GO:0009374 | biotin binding(GO:0009374) |
| 0.9 | 3.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.9 | 3.5 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.9 | 2.6 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.9 | 8.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.9 | 3.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.9 | 6.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.9 | 10.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.9 | 11.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.9 | 4.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.9 | 3.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.9 | 7.7 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.8 | 3.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.8 | 5.9 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.8 | 2.5 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.8 | 98.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.8 | 3.4 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.8 | 5.9 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.8 | 2.5 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.8 | 7.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.8 | 6.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.8 | 2.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.8 | 4.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.8 | 5.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.8 | 4.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.8 | 3.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.8 | 4.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.8 | 5.7 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.8 | 14.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.8 | 3.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.8 | 2.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.8 | 5.7 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.8 | 2.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.8 | 3.2 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.8 | 4.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.8 | 2.4 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.8 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.8 | 9.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.8 | 2.4 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.8 | 26.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.8 | 2.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.8 | 11.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.8 | 4.7 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.8 | 7.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.8 | 10.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.8 | 0.8 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
| 0.8 | 7.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.8 | 2.3 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.8 | 6.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.8 | 3.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.8 | 26.3 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
| 0.8 | 4.5 | GO:0004096 | catalase activity(GO:0004096) |
| 0.8 | 3.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.8 | 20.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.7 | 9.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.7 | 3.0 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.7 | 2.2 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.7 | 3.0 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.7 | 6.0 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.7 | 3.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.7 | 3.7 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.7 | 5.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.7 | 1.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.7 | 0.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.7 | 18.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.7 | 3.7 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.7 | 9.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.7 | 3.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.7 | 5.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.7 | 5.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.7 | 4.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.7 | 2.9 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.7 | 7.2 | GO:0005497 | androgen binding(GO:0005497) |
| 0.7 | 3.6 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.7 | 2.9 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.7 | 7.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.7 | 2.9 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.7 | 45.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.7 | 2.1 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.7 | 54.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.7 | 2.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.7 | 2.1 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 0.7 | 2.1 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.7 | 5.7 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.7 | 3.5 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.7 | 1.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.7 | 2.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.7 | 18.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.7 | 3.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.7 | 2.1 | GO:0030272 | cyclo-ligase activity(GO:0016882) 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.7 | 4.9 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.7 | 10.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.7 | 6.3 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.7 | 18.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.7 | 2.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.7 | 40.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.7 | 3.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.7 | 1.4 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.7 | 15.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.7 | 2.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.7 | 3.4 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.7 | 1.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.7 | 0.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.7 | 6.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.7 | 6.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.7 | 2.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.7 | 10.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.7 | 1.4 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.7 | 8.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.7 | 38.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.7 | 19.6 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.7 | 4.7 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.7 | 2.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.7 | 3.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.7 | 2.7 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.7 | 3.3 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.7 | 8.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.7 | 7.3 | GO:0046790 | virion binding(GO:0046790) |
| 0.7 | 3.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.7 | 2.6 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.7 | 19.7 | GO:0043495 | protein anchor(GO:0043495) |
| 0.7 | 2.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.7 | 3.3 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.7 | 0.7 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.7 | 48.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.7 | 3.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.7 | 2.0 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.7 | 4.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.6 | 2.6 | GO:0016530 | metallochaperone activity(GO:0016530) |
| 0.6 | 3.2 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.6 | 9.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.6 | 1.9 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.6 | 0.6 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.6 | 1.9 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.6 | 3.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.6 | 3.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.6 | 2.5 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.6 | 165.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.6 | 2.5 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.6 | 4.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.6 | 2.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.6 | 4.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.6 | 1.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.6 | 6.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.6 | 1.2 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
| 0.6 | 2.5 | GO:0004325 | ferrochelatase activity(GO:0004325) |
| 0.6 | 2.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.6 | 2.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.6 | 1.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.6 | 2.5 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.6 | 1.2 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.6 | 1.2 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.6 | 4.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.6 | 10.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.6 | 4.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.6 | 2.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.6 | 2.4 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.6 | 1.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.6 | 11.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.6 | 4.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.6 | 3.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.6 | 20.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.6 | 4.8 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.6 | 5.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.6 | 1.8 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.6 | 5.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.6 | 1.8 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.6 | 19.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.6 | 2.9 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.6 | 0.6 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.6 | 2.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.6 | 4.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.6 | 4.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.6 | 1.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.6 | 2.9 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.6 | 1.7 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.6 | 9.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.6 | 2.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.6 | 4.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.6 | 2.3 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.6 | 2.8 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.6 | 1.7 | GO:0016918 | retinal binding(GO:0016918) |
| 0.6 | 0.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.6 | 16.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.6 | 1.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.6 | 3.9 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.6 | 15.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.6 | 1.7 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.6 | 1.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
| 0.6 | 2.2 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.6 | 4.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.6 | 2.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.6 | 18.7 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.6 | 2.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.5 | 2.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.5 | 9.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.5 | 7.7 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.5 | 1.6 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.5 | 19.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.5 | 7.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.5 | 3.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.5 | 3.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.5 | 7.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.5 | 5.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.5 | 3.2 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.5 | 7.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.5 | 1.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.5 | 3.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.5 | 11.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.5 | 0.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.5 | 3.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.5 | 3.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.5 | 13.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.5 | 3.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.5 | 5.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.5 | 6.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.5 | 1.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.5 | 11.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.5 | 2.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.5 | 2.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.5 | 7.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.5 | 2.1 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.5 | 5.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.5 | 5.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.5 | 5.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.5 | 12.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.5 | 2.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.5 | 1.0 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.5 | 1.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.5 | 4.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.5 | 1.5 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.5 | 0.5 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.5 | 5.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.5 | 0.5 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
| 0.5 | 4.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.5 | 3.0 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.5 | 1.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.5 | 9.6 | GO:0071949 | FAD binding(GO:0071949) |
| 0.5 | 4.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.5 | 14.1 | GO:0005536 | glucose binding(GO:0005536) |
| 0.5 | 2.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.5 | 2.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.5 | 4.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.5 | 1.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.5 | 2.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.5 | 39.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.5 | 1.5 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.5 | 8.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.5 | 9.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.5 | 3.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.5 | 1.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.5 | 1.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.5 | 7.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.5 | 3.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.5 | 4.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.5 | 2.8 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.5 | 0.9 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.5 | 6.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.5 | 3.3 | GO:0042806 | fucose binding(GO:0042806) |
| 0.5 | 2.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.5 | 9.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.5 | 0.9 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.5 | 1.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.5 | 29.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.5 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.5 | 1.9 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.5 | 1.4 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.5 | 3.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.5 | 2.8 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.5 | 1.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.5 | 1.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.5 | 3.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.5 | 0.9 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.5 | 7.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.5 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.5 | 23.3 | GO:0070888 | E-box binding(GO:0070888) |
| 0.5 | 9.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.5 | 2.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.5 | 28.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.5 | 2.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.5 | 1.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.5 | 6.8 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.5 | 1.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.5 | 3.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.5 | 10.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.5 | 1.8 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
| 0.5 | 2.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.5 | 19.8 | GO:0043531 | ADP binding(GO:0043531) |
| 0.4 | 3.1 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.4 | 1.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.4 | 1.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.4 | 4.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.4 | 2.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.4 | 1.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.4 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.4 | 2.2 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.4 | 4.0 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.4 | 1.3 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.4 | 7.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.4 | 7.9 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.4 | 2.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.4 | 3.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.4 | 1.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.4 | 4.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.4 | 6.9 | GO:0005537 | mannose binding(GO:0005537) |
| 0.4 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.4 | 2.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.4 | 1.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.4 | 8.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.4 | 1.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.4 | 1.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.4 | 8.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.4 | 2.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 2.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.4 | 1.7 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.4 | 1.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.4 | 6.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.4 | 2.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.4 | 3.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.4 | 2.9 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.4 | 1.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.4 | 1.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.4 | 40.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.4 | 1.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.4 | 1.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.4 | 6.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.4 | 9.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.4 | 6.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.4 | 2.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 7.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.4 | 4.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.4 | 0.4 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.4 | 4.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.4 | 19.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.4 | 1.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.4 | 2.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.4 | 6.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.4 | 4.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.4 | 2.0 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.4 | 12.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.4 | 1.2 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.4 | 1.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.4 | 3.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.4 | 22.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.4 | 4.3 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
| 0.4 | 2.4 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.4 | 2.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.4 | 0.4 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.4 | 1.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.4 | 2.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.4 | 2.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.4 | 2.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.4 | 1.5 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.4 | 12.7 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.4 | 1.9 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.4 | 5.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.4 | 14.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.4 | 1.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.4 | 3.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.4 | 1.5 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.4 | 1.1 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.4 | 2.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.4 | 3.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.4 | 0.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.4 | 9.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.4 | 6.4 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.4 | 1.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.4 | 1.5 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.4 | 0.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.4 | 1.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.4 | 17.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.4 | 1.5 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.4 | 1.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.4 | 3.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.4 | 1.1 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.4 | 4.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.4 | 3.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.4 | 3.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.4 | 10.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.4 | 4.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.4 | 1.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.4 | 2.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.4 | 4.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.4 | 2.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.4 | 0.7 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.4 | 2.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.4 | 1.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.4 | 1.4 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.4 | 2.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.4 | 15.1 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.4 | 1.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.4 | 5.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.4 | 1.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.4 | 0.4 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.4 | 4.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.4 | 4.2 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.4 | 3.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.4 | 9.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.3 | 2.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.3 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
| 0.3 | 2.1 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.3 | 0.7 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.3 | 1.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.3 | 3.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.3 | 2.7 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.3 | 15.4 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.3 | 7.9 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.3 | 3.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.3 | 2.7 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.3 | 1.0 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.3 | 1.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.3 | 35.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.3 | 1.0 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.3 | 0.7 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.3 | 1.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.3 | 4.0 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.3 | 1.0 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.3 | 1.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.3 | 14.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.3 | 9.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.3 | 13.2 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.3 | 1.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.3 | 7.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.3 | 0.7 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.3 | 1.0 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.3 | 1.0 | GO:0019961 | interferon binding(GO:0019961) |
| 0.3 | 1.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.3 | 5.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.3 | 1.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.3 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.3 | 29.8 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
| 0.3 | 0.6 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.3 | 1.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.3 | 1.6 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.3 | 7.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.3 | 15.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.3 | 1.0 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.3 | 1.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.3 | 4.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.3 | 2.2 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.3 | 1.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.3 | 1.6 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.3 | 1.3 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.3 | 1.6 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.3 | 0.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.3 | 2.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.3 | 2.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.3 | 3.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.3 | 1.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.3 | 1.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.3 | 3.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.3 | 2.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.3 | 1.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.3 | 0.3 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.3 | 1.5 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.3 | 1.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.3 | 8.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.3 | 7.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.3 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.3 | 1.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.3 | 9.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.3 | 0.6 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.3 | 0.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.3 | 0.9 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 1.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.3 | 27.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.3 | 1.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.3 | 3.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.3 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.3 | 1.8 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.3 | 3.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.3 | 4.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.3 | 4.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.3 | 9.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.3 | 7.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.3 | 2.6 | GO:0008430 | selenium binding(GO:0008430) |
| 0.3 | 25.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.3 | 9.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.3 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.3 | 3.5 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.3 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.3 | 1.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.3 | 2.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.3 | 1.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.3 | 1.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.3 | 1.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.3 | 3.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.3 | 1.1 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.3 | 5.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.3 | 16.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.3 | 8.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.3 | 22.1 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.3 | 7.8 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.3 | 12.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.3 | 4.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.3 | 1.1 | GO:0035501 | MH2 domain binding(GO:0035500) MH1 domain binding(GO:0035501) |
| 0.3 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.3 | 0.6 | GO:0000035 | acyl binding(GO:0000035) |
| 0.3 | 0.3 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
| 0.3 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.3 | 1.1 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.3 | 0.8 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.3 | 9.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.3 | 7.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.3 | 2.7 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.3 | 0.8 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.3 | 2.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.3 | 2.7 | GO:0060229 | lipase activator activity(GO:0060229) |
| 0.3 | 80.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.3 | 75.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.3 | 4.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.3 | 1.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 0.5 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.3 | 5.0 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.3 | 3.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.3 | 2.9 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.3 | 3.2 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.3 | 2.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.3 | 0.8 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.3 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.3 | 5.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.3 | 8.3 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
| 0.3 | 1.0 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 2.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.3 | 2.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 0.8 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.3 | 0.8 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.3 | 0.8 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.3 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.3 | 12.6 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
| 0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.3 | 4.5 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.3 | 5.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 7.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.3 | 6.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.3 | 1.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.2 | 1.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.2 | 2.0 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 1.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.2 | 2.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 0.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
| 0.2 | 10.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
| 0.2 | 1.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.2 | 1.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.2 | 3.4 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 4.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 3.1 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.2 | 3.3 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.2 | 3.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.2 | 4.0 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.2 | 0.7 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.2 | 0.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.2 | 22.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.2 | 1.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.2 | 21.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.2 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.2 | 0.9 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.2 | 2.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.2 | 4.9 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.2 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.2 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.2 | 3.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 19.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 0.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.2 | 1.6 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
| 0.2 | 1.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 2.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 0.7 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.2 | 33.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.2 | 1.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.2 | 8.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.2 | 1.3 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.2 | 2.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 3.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 0.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.2 | 3.7 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.2 | 3.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 15.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.2 | 0.9 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.2 | 24.8 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.2 | 1.9 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.2 | 0.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
| 0.2 | 1.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.2 | 1.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.2 | 0.6 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
| 0.2 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.2 | 0.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) purine deoxyribonucleotide binding(GO:0032554) |
| 0.2 | 1.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.2 | 5.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.2 | 1.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.2 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 1.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 5.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.2 | 2.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 6.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.2 | 0.8 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.2 | 4.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.2 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.2 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 3.8 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.2 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.2 | 4.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.2 | 6.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.2 | 3.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 1.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.2 | 0.6 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
| 0.2 | 4.2 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.2 | 1.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 0.8 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.2 | 2.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.2 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 283.4 | GO:0003723 | RNA binding(GO:0003723) |
| 0.2 | 1.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 2.0 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
| 0.2 | 0.4 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 0.2 | 2.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 1.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
| 0.2 | 0.7 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.2 | 5.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.2 | 4.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.2 | 8.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.2 | 8.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.2 | 6.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.2 | 0.7 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.2 | 0.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.2 | 0.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.2 | 0.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.2 | 1.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.2 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.2 | 1.2 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.2 | 0.5 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.2 | 3.3 | GO:0019841 | retinol binding(GO:0019841) |
| 0.2 | 3.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.2 | 0.5 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.2 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.2 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.2 | 2.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.2 | 3.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 0.2 | 0.3 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
| 0.2 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.2 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.2 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 1.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.2 | 17.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.2 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.2 | 1.4 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.2 | 1.4 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.2 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.2 | 1.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.2 | 0.9 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.2 | 0.5 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.2 | 7.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.1 | 3.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 1.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.1 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.1 | 4.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 1.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.1 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.1 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.1 | 1.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.1 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 1.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 0.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.1 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.1 | 6.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.1 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.1 | 1.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 2.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 0.7 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.1 | 0.5 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.1 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.7 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.1 | 1.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 18.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 12.6 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 0.6 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.1 | 0.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.1 | 1.3 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.4 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 0.1 | GO:1901474 | azole transmembrane transporter activity(GO:1901474) |
| 0.1 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 23.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.1 | 1.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 0.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 2.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 0.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.1 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 2.5 | GO:0048029 | monosaccharide binding(GO:0048029) |
| 0.1 | 1.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 5.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.1 | 0.4 | GO:0038047 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
| 0.1 | 53.2 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
| 0.1 | 0.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.1 | 1.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.1 | 0.4 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
| 0.1 | 0.3 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.1 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 0.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 1.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.1 | 7.4 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 1.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 0.4 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.1 | 0.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.1 | 20.6 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 1.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 0.1 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.1 | 0.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.1 | 4.9 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.1 | 1.0 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.1 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.1 | 1.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.1 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 2.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.1 | 2.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.1 | 0.7 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.1 | 0.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.1 | 2.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 1.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.6 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 2.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 9.0 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 1.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.1 | 1.9 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.1 | 0.5 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.1 | 3.0 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 5.1 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.2 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.1 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.1 | 0.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.1 | 2.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 2.1 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.1 | 12.4 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.1 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 0.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.1 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.1 | 0.2 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.1 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 21.1 | GO:0003779 | actin binding(GO:0003779) |
| 0.1 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.1 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.1 | 1.0 | GO:0051287 | NAD binding(GO:0051287) |
| 0.1 | 10.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.1 | 0.2 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.1 | 14.9 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
| 0.1 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.0 | 0.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.0 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.0 | 10.4 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
| 0.0 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.0 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.0 | 0.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.0 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.0 | 0.6 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.0 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.0 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.0 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 1.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
| 0.0 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.0 | 0.1 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.0 | 51.4 | GO:0003676 | nucleic acid binding(GO:0003676) |
| 0.0 | 1.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.1 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
| 0.0 | 2.6 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.0 | 1.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.0 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.0 | 0.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.0 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.1 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
| 0.0 | 0.0 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.6 | GO:0019903 | protein phosphatase binding(GO:0019903) |
| 0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 0.1 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.0 | 1.3 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
| 0.0 | 0.6 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 3.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 1.2 | 3.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 1.1 | 23.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 1.1 | 3.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 1.1 | 7.4 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.9 | 58.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.8 | 32.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.8 | 13.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.8 | 71.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.8 | 36.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.8 | 33.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.7 | 17.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.7 | 53.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.7 | 1.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.7 | 38.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.6 | 59.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.6 | 21.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.6 | 33.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.6 | 6.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.6 | 42.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.6 | 2.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.5 | 58.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.5 | 22.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.5 | 4.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.5 | 6.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.5 | 15.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.5 | 1.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.5 | 6.1 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.5 | 1.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.5 | 10.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.5 | 24.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.5 | 35.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.5 | 6.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.5 | 31.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.5 | 3.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.5 | 5.6 | PID MYC PATHWAY | C-MYC pathway |
| 0.5 | 19.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.5 | 26.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.5 | 34.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.4 | 13.0 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.4 | 7.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.4 | 10.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.4 | 6.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.4 | 16.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 12.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.4 | 20.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.4 | 59.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.4 | 17.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.4 | 26.3 | PID FOXO PATHWAY | FoxO family signaling |
| 0.4 | 16.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.4 | 4.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.4 | 4.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.4 | 26.9 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.4 | 5.1 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.4 | 21.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.4 | 7.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.3 | 3.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.3 | 13.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.3 | 6.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.3 | 11.9 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.3 | 2.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.3 | 30.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.3 | 1.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.3 | 19.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.3 | 10.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.3 | 16.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.3 | 2.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.3 | 10.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.3 | 11.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.3 | 5.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.3 | 3.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.3 | 2.2 | PID EPO PATHWAY | EPO signaling pathway |
| 0.3 | 8.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.3 | 10.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 5.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 6.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.2 | 20.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.2 | 79.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 10.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 9.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.2 | 5.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.2 | 1.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 53.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 12.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.2 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 4.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 8.0 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.2 | 6.7 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.2 | 9.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 1.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.2 | 18.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.2 | 3.9 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.2 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.2 | 4.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 10.3 | PID P73PATHWAY | p73 transcription factor network |
| 0.1 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 0.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 0.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 2.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 4.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 7.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 1.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 1.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 5.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 2.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 3.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 2.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 4.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 2.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 2.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 2.0 | 41.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 1.6 | 118.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 1.4 | 43.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 1.3 | 22.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 1.2 | 8.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 1.2 | 19.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 1.2 | 34.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 1.1 | 20.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 1.1 | 5.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 1.0 | 25.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 1.0 | 23.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 1.0 | 53.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 1.0 | 9.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.9 | 24.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.9 | 51.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.9 | 26.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.9 | 37.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.9 | 35.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.9 | 25.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.9 | 38.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.9 | 61.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.8 | 3.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.8 | 72.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.8 | 35.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.8 | 0.8 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
| 0.8 | 15.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.8 | 51.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.8 | 27.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.8 | 23.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.7 | 14.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.7 | 3.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.7 | 34.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.7 | 10.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.7 | 10.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.7 | 3.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.7 | 11.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.7 | 11.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.7 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.7 | 17.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.7 | 20.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.7 | 18.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.7 | 9.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.6 | 14.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.6 | 36.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.6 | 69.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.6 | 28.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.6 | 19.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.6 | 15.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.6 | 52.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.6 | 23.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.6 | 1.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.6 | 3.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.6 | 15.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.6 | 8.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.6 | 4.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.6 | 5.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.6 | 26.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.6 | 19.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.6 | 6.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.6 | 8.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.6 | 32.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.6 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.6 | 6.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.6 | 18.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.6 | 15.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.6 | 4.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.6 | 12.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.6 | 15.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.6 | 3.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.6 | 11.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.6 | 106.6 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.6 | 15.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.6 | 22.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.5 | 11.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.5 | 19.7 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
| 0.5 | 21.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.5 | 12.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.5 | 14.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.5 | 10.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.5 | 3.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.5 | 5.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.5 | 19.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.5 | 31.2 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.5 | 15.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.5 | 4.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.5 | 15.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.5 | 19.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.5 | 32.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.5 | 1.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.5 | 4.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.5 | 12.9 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 0.5 | 7.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.5 | 41.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.4 | 8.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.4 | 13.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.4 | 6.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.4 | 6.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.4 | 13.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.4 | 28.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.4 | 26.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.4 | 13.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.4 | 11.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.4 | 70.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.4 | 0.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.4 | 44.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.4 | 14.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.4 | 4.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.4 | 7.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.4 | 3.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.4 | 15.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.4 | 8.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.4 | 4.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.3 | 86.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.3 | 3.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.3 | 11.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.3 | 1.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.3 | 9.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.3 | 4.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.3 | 7.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.3 | 1.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.3 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.3 | 7.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.3 | 21.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.3 | 13.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.3 | 2.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.3 | 2.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.3 | 6.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.3 | 7.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.3 | 3.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.3 | 4.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.3 | 3.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.3 | 2.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 3.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.3 | 4.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 3.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.3 | 9.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.3 | 4.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.3 | 2.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.3 | 21.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.2 | 5.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.2 | 17.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
| 0.2 | 12.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 5.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 15.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.2 | 2.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.2 | 10.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.2 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.2 | 4.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.2 | 8.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.2 | 2.9 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.2 | 3.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.2 | 3.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.2 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.2 | 4.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 9.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.2 | 16.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.2 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.2 | 5.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.2 | 3.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.2 | 0.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.2 | 5.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.2 | 2.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.2 | 0.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.2 | 16.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.2 | 1.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.2 | 2.8 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
| 0.2 | 7.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 5.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 4.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 1.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 4.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 2.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.1 | 3.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 3.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.1 | 2.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 2.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.1 | 2.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 2.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.1 | 2.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 1.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 3.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 2.3 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
| 0.1 | 2.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 3.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 4.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 3.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.1 | 2.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 2.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 3.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 5.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.1 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.1 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 3.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.1 | 2.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 3.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 5.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 7.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.0 | 2.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 1.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.0 | 3.7 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 1.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 2.3 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.0 | 0.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.0 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.0 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |